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ABSTRACT
STRUCTURE AND THERMODYNAMICS OF POLYGLUTAMINE PEPTIDES
AND AMYLOID FIBRILS VIA METADYNAMICS AND MOLECULAR
DYNAMICS SIMULATIONS
By
Riley J. Workman
August 2018
Dissertation supervised by Jeffrey D. Evanseck
Aggregation of polyglutamine (polyQ)-rich polypeptides in neurons is a marker
for nine neurodegenerative diseases. The molecular process responsible for the for-
mation of polyQ fibrils is not well understood and represents a growing area of study.
To enable development of treatments that could interfere with aggregation of polyQ
peptides, it is crucial to understand the molecular mechanisms by which polyQ pep-
tides aggregate into fibrils. Many experimental techniques have been employed to
probe polyQ aggregation, however, observations from these studies have not lead to
a unified understanding of the properties of these systems, instead yielding compet-
ing, fragmented theories of polyQ aggregation. This dissertation addresses these gaps
in knowledge by shedding light on important steps of the aggregation process. The
structural motif of polyQ fibrils is not agreed upon in the field, which is worrying,
given that these structures are the endpoint of polyQ aggregation. Here, molecular
dynamics (MD) simulations paired with UV resonance Raman (UVRR) experiments
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show that short polyQ peptides adopt extended antiparallel β-sheet fibrils, contrary
to β-hairpin structures oft predicted in the polyQ field. The structure of monomeric
polyQ peptides was then studied to gain insight into the beginnings of the aggre-
gation mechanism. Metadynamics MD simulations were used to characterize the
conformational energy landscape of polyQ peptides, and this data was compared to
experimental UVRR results. We found short polyQ peptides can adopt PPII-rich
and collapsed β-strand monomeric structures, which establishes that polyQ can form
distinct conformational states as monomers. The effect of increased polyQ repeat
length was also tested, and it was found that increased repeat length corresponds to
lower energy barriers between monomeric conformational states, which may explain
why longer polyQ repeats are quicker to aggregate. Hydrogen bonding strengths of
polyQ monomers and fibrils were also investigated with MD and UVRR, showing
that polyQ peptides favor intrapeptide hydrogen bonds over those between peptide
and water. Overall, the work in this dissertation deepens the understanding of the
polyQ aggregation mechanism by determining the structure and thermodynamics of
monomeric and fibrillar states, as well as identifying polyQ peptide hydrogen bonding
as one of the driving forces in these systems. This knowledge can aid the development
of molecular mechanisms to interfere with the formation of toxic polyQ aggregates
that trigger the onset of polyQ diseases.
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Chapter 1. INTRODUCTION TO POLYGLUTAMINE AGGREGATION
RESEARCH AND MOLECULAR DYNAMICS
1.1 Introduction
The study of polypeptide aggregation has become an area of intense interest fol-
lowing the discovery that the formation of proteinaceous aggregates is a hallmark of
the molecular pathology of various neurodegenerative diseases, such as Alzheimer’s,1
Parkinson’s,2 and Huntington’s disease.3 In these diseases, the protein-rich aggregates
share specific structural traits, such as high β-sheet content, fibrillar morphologies,
and aqueous insolubility, and are collectively categorized as “amyloid” fibrils.4,5 The
disease state for each of these diseases is linked to a different protein: β-amyloid,
α-synuclein, and huntingtin for Alzheimer’s,1 Parkinson’s,2 and Huntington’s3 re-
spectively. Although these proteins lack similar sequence or function, they aggregate
into fibrils with remarkably similar features, including major β-sheet structure, bind-
ing of thioflavin-T, and insolubility.4,6 This property has led many to conclude that
there must be significant similarities in the molecular pathology of these diseases.4,6–8
In this dissertation, peptide systems associated with one subclass of these diseases,
polyglutamine (polyQ) diseases, which includes Huntington’s disease, are studied to
better understand the molecular structures that play a role in the aggregation of
polyQ peptides.
1.2 PolyQ Diseases
Aggregation of polyQ-rich polypeptides in neurons is a pathological marker of nine
known neurodegenerative diseases.9–11 Each polyQ disease is caused by mutations that
result in expanded CAG codon repeats in various genes, which consequently impart
glutamine amino acid repeat expansions into the proteins encoded by the mutated
genes.10–12 These elongated polyQ tracts cause the affected proteins to misfold in the
cell and associate into peptide aggregates that mature into fibrils.9–11 The amount
of glutamine repeats necessary to cause disease states differs per polyQ disease; each
1
disease possesses a critical value of repeats that elicits the disease.10,13 Table 1.1 shows
the different associated proteins and critical repeat lengths for the nine polyQ diseases
that have been identified.
PolyQ disease Associated protein Critical repeat length
Dentatorubropallidoluysian atrophy Atrophin-1 49
Huntington’s disease Huntingtin 36
Spinobulbar muscular atrophy Androgen receptor 38
Spinocerebellar ataxia 1 Ataxin-1 49
Spinocerebellar ataxia 2 Ataxin-2 33
Spinocerebellar ataxia 3 Ataxin-3 55
Spinocerebellar ataxia 6 CaV 2.1 21
Spinocerebellar ataxia 7 Ataxin-7 38
Spinocerebellar ataxia 17 TBP 47
Table 1.1: PolyQ disease types14
The fact that longer repeat lengths trigger the onset of polyQ diseases indicates
that an increase in polyQ tract length speeds up the kinetics of the peptide aggrega-
tion process.15 The kinetics of polyQ and, in general, amyloid fibril formation occur
via a nucleation and growth mechanism,6,16 although the molecular details of this
mechanism are not well understood. It is thought that longer polyQ repeats has-
ten the occurrence of a nucleating event that allows fibril growth to take place.16–19
This fits with the disease pathology of polyQ diseases where affected individuals with
longer polyQ repeat lengths generally show onset of the disease at younger ages.9–11
It is important to note that the precise role that the phenomenon of polyQ peptide
aggregation and fibril formation plays in the disease state has not been established.
Initially, the consensus was that the physical presence of these large fibrils, also known
as cellular inclusions, disrupted natural cellular function in a cytotoxic way.6,9,20 How-
ever, this hypothesis has been undermined by the observation that the presence of
large inclusions actually extends the life of neurons by sequestering intracellular polyQ
peptides.21 The prevalent hypothesis is now that mature cellular fibrils do not play
a harmful role to cellular function; rather it has been reported that smaller, soluble
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polyQ aggregates act as the cytotoxic agents in these diseases.18,22,23 There are vary-
ing theories as to why this is the case, however most studies correlate these species
translocating into the nucleus with cytotoxicity.
1.3 Experimental Approaches
The study of polyQ aggregation, and indeed many other amyloid diseases, has ben-
efited greatly from the fact that polyQ peptides aggregate to form fibrils in vitro that
are structurally identical to those formed in vivo. This indicates that the aggregatory
behavior of these peptides is not dependent on an intracellular environment and is
instead a more general chemicophysical phenomenon that can be understood outside
the constraints of a biological scope. A rich variety of experimental techniques have
been utilized to probe the behavior of polyQ systems, including but not limited to cir-
cular dichroism (CD) spectroscopy,20,24,25 electron microscopy (EM),17,26–28 solid-state
nuclear magnetic resonance (NMR) spectroscopy,29,30 infrared spectroscopy,31,32 UV
resonance Raman (UVRR) spectroscopy,25,33–35 and X-ray diffraction,28,36,37 as well
as numerous kinetic and thermodynamic biochemical assays.8,12,38 The results from
many of these variant experimental studies have not given rise to a unified consensus
as to the properties and behavior of these systems, but have instead have yielded
a myriad of competing, fragmented theories of the aggregative behavior of polyQ
peptides and fibrils.
Inconsistency in the conclusions drawn from the experimental study of polyQ
systems is caused by the significant qualitative interpretation necessary to transform
experimental measurements into detailed molecular understanding of the structural
dynamics of polyQ peptides. For example, diffraction patterns must be translated into
structural models consistent with the data,36,37 frequency shifts must be deciphered
to identify the chemical phenomena at play,25,29,31 and at the end of the day, many
experimental analysis methods are simply not incisive enough to yield the types of
observations that will contribute greatly to the understanding of polyQ aggregation.
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The dissonance of experimental conclusions in the field of polyQ aggregation has
made clear the need for alternate methods of investigation that can accompany and
sharpen experimental findings.
1.4 Computational Methods
In the years since the development of the field of polyQ aggregation, computational
simulations, in particular those using molecular dynamics (MD), have become an
increasingly prevalent tool in the study of biophysical systems.39,40 MD simulations
allow researchers to probe systems similar to those prepared in the laboratory at
the molecular scale, enabling examination at a finer level than most experimental
techniques can offer. The method was originally reported in a communication from
Los Alamos National Laboratory by Fermi et al. and later pioneered in the study
of biological systems by Karplus, Levitt, and Warshel,41,42 as recognized in their
2013 collective Nobel Prize in chemistry. This dissertation makes significant use of
MD simulations, and for that reason a short introduction of the physics of these
simulations is discussed here.
MD makes use of Newton’s fundamental laws of motion40,43 to simulate the move-
ments of the atoms that make up biomolecules. The forces at play in these atomistic
systems are calculated with force fields, which are simply the equations and accom-
panying parameters used to calculate potential energy and force on the atoms.44 In
modern MD, the velocity Verlet integration algorithm,45,46 shown in Equations 1.1
and 1.2, is used to calculate the trajectories of the atoms in the system.
~q(t+ δt) = ~q(t) + ~vδt+
1
2
~a(t)δt2 (1.1)
~v(t+ δt) = ~v(t) +
1
2
(
~a(t) + ~a(t+ δt)
)
δt (1.2)
In this algorithm, ~q(t) is atomic coordinates at time t, ~v(t) is atomic velocities at
time t, ~a(t) is atomic acceleration at time t, and δt is a small time increment known
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as the time step. As the algorithm shows, ~q and ~v can be obtained for some future
time t + δt, but this is not the case for ~a. To calculate ~a at a new configuration,
Newtons second law of motion (Equation 1.3) is used to calculate ~a(t) from the force
on the atom at time t.
~a(t) =
~F (~q(t))
m
(1.3)
As indicated in Equation 1.3, the force ~F on an atom is a function of only the
atomic coordinates ~q(t). Because of this, ~F can be calculated from any molecular
configuration. In MD simulations, a force field is used to calculate force from the
potential energy function of the system via the relationship show below.
~F (~q(t)) = −∇U(~q(t)) ≡ −
(
∂
∂x
U
(
~q(t)
)
+
∂
∂y
U
(
~q(t)
)
+
∂
∂z
U
(
~q(t)
))
(1.4)
Confusingly, force fields are actually defined as the potential energy function,
U(~q(t)), and accompanying parameters, and the gradient of this function (Equa-
tion 1.4) is used to calculate the force. The relationships contained in Equations 1.1,
1.2, 1.3, and 1.4 form the central mathematical machinery used to perform MD sim-
ulations.
The force field is incredibly important in the accuracy of MD simulations. In
the last 25 years, common force fields such as CHARMM47 and Amber48 have been
continually improved and refined. Force fields are, for the most part, empirically
derived and, thus, many approximations and simplifications are made concerning the
physics of the system.49 For example, in MD simulations electrons are not treated
explicitly; instead atoms are treated as spheres that possess a predefined partial
charge related to the dipoles and relative electronegativities of the molecule. Common
potentials used to model the bonding, angular, and torsional energies in covalently
bound molecules are shown in Equations 1.5, 1.6, and 1.7.44,48,50
5
U ijb (r) =
1
2
kb(rij − rb)2 (1.5)
U ijka (θ) =
1
2
ka(θijk − θa)2 (1.6)
U ijkld (φ) = ka
[
1 + cos(nφijkl − δ)
]
(1.7)
In Equations 1.5, 1.6, and 1.7, U ijb is the bond stretching energy between atoms
i, j, U ijka is the angular energy between atoms i, j, k, and U
ijkl
d is the dihedral en-
ergy between i, j, k, l. kb, ka, and kd are force constants for bond, angle, and dihedral
potentials, rb, θa, and δ are equilibrium values for bonds, angles, and dihedrals, and
rij, θijk, and nφijkl are the current values of each. These potential functions have the
benefit of being simple and easily differentiable with respect to x, y, z, which allows
calculation of force, but they are also ideal, symmetrical functions that neglect the
effect of quantum mechanical phenomena such as anharmonicity and vibrational cou-
pling.44,48,51 Equations 1.8 and 1.9 show the two primary forms of nonbonded atomic
interaction potentials in common force fields: the Lennard-Jones52 (Equation 1.8)
and Coulombic (Equation 1.9) potentials.
U ijLJ(rij) = 4ij
[(
σij
rij
)12
−
(
σij
rij
)6]
(1.8)
U ijC (rij) =
1
4piε0
· qiqj
rij
(1.9)
In both nonbonded potentials, rij indicates the distance between atoms i and
j. In the Lennard-Jones equation, ij and σij are respectively the strength of the
attractive interaction between atoms i and j and the distance at which the energy
is zero. For the Coulombic potential, ε0 stands for the permittivity of vacuum, and
qi and qj are the partial charges on atoms i and j. These nonbonded potentials
are also empirical approximations: ULJ models weak attractive and strong repulsive
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forces such as London dispersion forces and volume overlap repulsion and UC models
like-charge repulsion and opposite-charge attraction.
All molecules simulated with MD are chemically inert and only interact with other
molecules via electrostatics and van der Waals forces; bonds cannot break or form.
Responsible usage of MD requires the identification of the force field most suited to
studying the system of interest.53,54 After the evaluation of several force fields55,56 for
use in simulating polyQ peptides, the CHARMM3650 force field was chosen and is
used for the most part in this dissertation.
1.5 Importance of Computational and Experimental Collaboration
Most biophysics experiments measure average properties of the sample of in-
terest,57 but MD allows one to monitor the structure and dynamics of individual
molecules in a system;39,49 although average properties of the sample may still be
computed and compared to experimental data.58 The real power of computational
techniques like MD lies in this potential for comparison to traditional experimental
methods.57,59 The atomistic dynamic and structural information that MD can report
is an excellent supplement to experimental studies; theoretical results can strengthen
and expand experimental observations while corroboration with experiment can help
validate computational models.39,46,60
1.6 Enhanced Sampling with Metadynamics
Many biological processes involve the formation of energetically unfavorable, and
thus transient, macromolecular structures. A majority of experiments cannot probe
these processes because analyses that respond to the average properties of a sample
by their nature cannot monitor short-lived, rare events. However, MD simulations
are able to probe these types of events robustly with a variety of computational tech-
niques known as enhanced sampling methods, including conformational flooding,61
replica-exchange molecular dynamics,62 free-energy perturbation,63 accelerated MD,64
and umbrella sampling.65 The work presented in this thesis utilizes one such method
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called metadynamics,66 based on the concept of conformational flooding, which en-
ables the efficient exploration and characterization of the structural energy landscape
of biomolecules.
Two important aspects of MD simulations are fundamentally limited. The first
deficiency is the inaccuracy of force fields, which has already been discussed. Sec-
ondly, MD simulations are held back by their high computational cost. Computation
of force in a typical MD simulation requires the evaluation of at least ∼NN−1 inter-
atomic potentials, which contain costly square root calculations.67 Consequently, MD
simulations require considerable resources to carry out. For example,68 1 µs of MD
simulation on a 25 000 atom system with 24 processors will take weeks or even months
of computation time and to simulate larger systems for this amount of time requires
petascale supercomputers to run quickly.69
This computing limitation often leads to inadequate sampling of conformational
states, disabling the simulation from giving insight into the nature of the system of
interest.67 In statistical mechanics, sampling refers to the amount of configurations, or
arrangements of atoms in a system, that can be accessed. Every atomic arrangement
has an associated free energy cost, and high free energy costs can require long time
scales to access. Groups of similar configurations are denoted as “states”, and each
landscape has different states with varying free energies. A conformational free energy
landscape with abundant deep energy states (wells) and high energy states (barriers)
is referred to as a “rugged” or “frustrated” landscape. Systems impeded by inadequate
simulation time and rugged free energy landscapes may become trapped in deep wells
at equilibrium, with insufficient thermal energy to traverse the associated barriers.69
Figure 1.1 depicts such a free energy landscape for an example biomolecule,
wherein the x−axis represents some measure of conformation (e.g. RMSD, dihedral
angle) and the y−axis represents the free energy cost to reach a certain conformation
on the landscape. The only way to enable a system such as the one shown in Figure 1.1
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Figure 1.1: Example conformational free energy landscape for a biomolecule. Two
deep energy wells (A and B) exist, but due to the temperature of the system, the
molecular may only climb so high up the energy barrier (dotted red line). Unfor-
tunately, at the time scale available for simulation, this system may not be able to
sample well B. Source: figure prepared with Python package Matplotlib and Adobe
Illustrator.
to sample state B is to raise the temperature high enough so the free energy of the
dotted red line in Figure 1.1 exceeds the height of free energy barrier. However, often
this is undesirable, as an elevated temperature causes the atoms to possess greater
velocities, potentially invalidating experimental comparison at room temperature,
for example. Although some enhanced sampling methods, such as replica-exchange
MD,62 do employ temperature jumps, temperatures are lowered back down after some
simulation time to allow new conformations to sample at reasonable conditions.
There are three main types of enhanced sampling methods. Methods like um-
brella sampling65 and free energy perturbation63 split the configurational space into
subsections called “windows” and multiple simulations are run with one simulation
sampling one window. Force constants65 or scaling parameters63 are used to restrict
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the sampling of each simulation to the associated window. This type of enhanced
sampling is robust if enough windows are able to be sampled, however if the windows
are too large the sampling can be insufficient.69 Also, these methods are not useful for
sampling an entire energy landscape for a complex system, as the number of required
simulation windows would be prohibitive.65
Another type, which was discussed briefly two paragraphs prior, are temperature
modulation methods such as replica-exchange MD.62 Sampling with these methods
involves temporarily boosting the temperature of the system, allowing it to reach
states that would be inaccessible at lower temperatures. These methods are well-
suited for speculative conformational searching, but lack the quantitative ability to
calculate the shape of the free energy landscape.66,67
The third type of enhanced sampling involves use of an alternate potential energy
function for the system that encourages efficient sampling of the conformational free
energy landscape. This family encompasses methods like metadynamics,66 confor-
mational flooding,61 and accelerated MD.64 These methods are particularly flexible
because they do not require the sampling of discrete windows, and, in the case of con-
formational flooding61 and metadynamics,66 allow the quantification of the sampled
free energy landscape.
The way methods like conformational flooding61 and metadynamics66 improve
sampling of frustrated free energy landscapes is by adding artificial energy to the
potential energy function at that causes deep energy wells to become more shallow.
After all rugged energy wells and barriers are sampled, the conformational energy
landscape flattens out and possesses equal probability states. This added energy
allows the system to efficiently escape energy minimi and traverse energy maxima
while still sampling according to the physics of the underlying free energy landscape.
In metadynamics,66 artificial energy is added to the potential energy of the sys-
tem as unnormalized Gaussian functions, or “hills”, the form of which is given in
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Equation 1.10.
UGauss(ξ) = W exp
(
− (ξ(t)− ξ(t− δt))
2
2σ2
)
(1.10)
Here, UGauss is the energy of one added Gaussian hill, W is the coefficient that
determines the height of the hill, σ represents the standard deviation of the Gaussian,
and ξ(t) and ξ(t − δt) are the positions on the conformational energy landscape at
times t and t + δt. Conformational energy landscapes are constructed using coordi-
nates that simplify three-dimensional space into “collective variables”.43,67,69 Collec-
tive variables allow the construction of conformational space using simple measures
of conformation that are functions of Cartesian coordinates, such as RMSD, radius
of gyration, and dihedral angles. In the metadynamics simulations presented herein,
ξ will be RMSD values with respect to the α-carbons of ideal secondary structures.
Values for W and σ in Equation 1.10 must be chosen with scrutiny: W must be
maximized while being less than the average force on the unbiased system, and σ
should be between 1
20
and 1
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of the length of the full conformational space.70 Laio et
al.70 discovered the estimated length of a metadynamics simulation can be formulated
as follows
ttotal =
∆G¯est
W
τGauss
(
∆ξ¯est
σ
)d
(1.11)
where ∆G¯est is the estimate of the highest free energy barrier to traverse, W is the
same from Equation 1.10, τGauss is the frequency in MD steps that Gaussian hills are
deposited, ∆ξ is the total width of the collective variable space, σ is the same from
Equation 1.10, and d is the number of dimensions that make up the collective variable
space. In the metadynamics simulations discussed in this dissertation, d = 3.
Figur 1.2 shows the same landscape depicted in Figure 1.1 but after metadynam-
ics has been used to sample energy well A. The added Gaussian energy cause the
potential energy of system to be high enough that it can easily mount the barrier
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Figure 1.2: Example conformational free energy landscape for a biomolecule. Two
deep energy wells (A and B) exist, and metadynamics sampling has been used to
add artificial energy (green hills) into energy well A to allow the system to climb
the barrier separating wells A and B. Source: figure prepared with Python package
Matplotlib and Adobe Illustrator.
and sample into well B. A useful property of metadynamics is that, with the his-
tory of deposited Gaussian hills in a simulation, one can recreate the conformational
free energy landscape sampled by the system during the simulation.66,70 This will
be used in this dissertation to explore and characterize the free energy landscape of
polyglutamine peptides.
1.7 Summary of Dissertation Work
Our goal in this dissertation was to better understand the structural properties of
polyQ peptides in various states that are present along the aggregation mechanism.
The mechanism by which polyQ peptides aggregate and eventually form insoluble
amyloid fibrils is not well understood. Understanding this mechanism is important
because polyQ diseases are reported to be primarily gain-of-function diseases.18,71,72
12
As a consequence, there is great interest in characterizing the molecular mech-
anisms at play in these diseases. Figure 1.3 shows a hypothetical polyQ aggrega-
tion mechanism25,27,73 constructed from various theories explaining the aggregation
of polyQ peptides.
Figure 1.3: Flowchart diagram illustrating various hypotheses for polyQ peptide
aggregation. The first row of the flowchart illustrates possible monomeric structures
for polyQ peptides that can induce various types of peptide dimerization events.
Posited dimer structures are shown in the middle row, leading to ordered aggregate
structures in the third row. Source: figure prepared with Adobe Illustrator.
There are two main theories for the molecular mechanism of polyQ aggregation.
One theory,8,12,13,27,30,37,74 called here “nucleation and growth”, states that polyQ
monomers come together to form an ordered β-hairpin or β-sheet oligomer, and
monomers are added on to this initial structure, allowing the aggregate to grow (shown
in the right and left pathways of Figure 1.3). Alternatively,19,73,75–78 the middle sec-
tion of Figure 1.3 shows another pathway, named here “disordered cluster”, where
polyQ monomers associate into disordered clusters of peptides that eventually convert
to the structurally ordered aggregates seen on the bottom right and left of the figure.
Accurately determining the molecular mechanism of aggregation for polyQ pep-
tides is key, because that knowledge can inform the search for treatment strategies
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for polyQ diseases.18,72 Several studies have reported molecules that are able to in-
terfere with the aggregation of the polyQ tract of the huntingtin protein, such as
Congo red,79 thioflavin S,80 and trehalose.81 However, due to lack of knowledge of
the aggregation mechanism it is unclear what polyQ species these molecules bind to
or inhibit.72 A complete picture of the aggregation mechanism could give researchers
the clarity required to identify specific molecular targets for inhibitors like these.
However, this picture must be built piecewise. Current simulation methods lack the
computing power to simulate the aggregation of polyQ fibrils en masse.40 Instead, an
understanding of specific steps of the flowchart in Figure 1.3 can be developed and
compiled into a singular theory for polyQ aggregation.
This dissertation contains work that deepens the understanding of the polyQ
aggregation mechanism by determining the structure of polyQ fibrils. As shown in
the bottom row of Figure 1.3, the field is unsure of the structural motif of polyQ
fibrillar aggregates: some reporting structures composed of β-hairpins36,37 and others
positing β-sheet fibrils formed extended β-strands.23,82 Understanding the structural
makeup of polyQ fibrils is essential to understanding the aggregation process, seeing
as fibrils are the endpoint of the mechanism.
The second chapter of this dissertation aimed to determine the structural propen-
sity of polyQ fibrils formed from short polyQ peptides. The structures of polyQ fibrils
composed of D2Q10K2 (Q10) peptides were investigated using classical MD simula-
tions and UVRR experiments. Three polymorphs of Q10 fibrils were simulated and
data was compared to UVRR results, showing that Q10 primarily adopts primarily
antiparallel extended β-sheet fibril structures while able to adopt minor populations
of parallel extended β-sheets. These results indicate that, at least for short polyQ
sequences, the β-hairpin-based aggregtion hypothesis shown as the right pathway in
Figure 1.3 is not the correct view. Rather, an aggregation mechanism ending with
extended antiparallel β-sheet fibrils (leftmost pathway in Figure 1.3) should be de-
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veloped.
In the third and fifth chapters of the dissertation, the first row of Figure 1.3,
monomeric polyQ structure, was investigated. In Chapter 3, we used metadynamics
MD simulations to characterize the conformational free energy landscape of aque-
ous, monomeric Q10 peptides. Results from these simulations were compared with
data from UVRR spectra of Q10, revealing that monomeric Q10 can adopt stable
collapsed β-strand and PPII-rich secondary structures. We observed a prohibitive
energy barrier separating these structures from a β-hairpin conformation, and thus
find it unlikely that Q10 forms such a structure. This observation supports our find-
ings from the first chapter that β-hairpins are not present on the Q10 aggregation
mechanism.
The fifth chapter contained a study in which we probed the monomeric structural
ensemble of longer D2Q15K2 (Q15) and D2Q20K2 (Q20) peptides to observe the effect
of increased repeat length on the structure of polyQ monomers. This is an important
case because it can forecast how the aggregation mechanisms depicted in Figure 1.3
would change given different polyQ sequences. The results of this study indicate that
increased polyQ length decreases the energy barrier separating β-strand and PPII-
rich secondary structures. This phenomenon may explain the earlier onset of polyQ
diseases that occurs with longer repeat lengths. It also indicates that monomeric
β-hairpins are still not present in longer polyQ sequences and likely do not play a
role in the early stages of aggregation.
Chapter 4 describes a study in which we investigated, in detail, the strengths of
various types of Q10 hydrogen bonding (H-bonding). Glutamine H-bonding is thought
to play an important role in the monomeric, oligomeric, and fibril structures in the
polyQ aggregation mechanism, and here MD simulations and UVRR demonstrated
that Q10 forms stronger intrapeptide H-bonds than those formed between the peptide
and water. This result strongly indicates that polyQ H-bonding is a driving force in
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the association of polyQ peptides, and points toward a possible strategy of disrupting
polyQ H-bonding to interfere with polyQ aggregation.
The goal of this dissertation was to provide insight into polyQ structural states
that exist along the aggregation pathway, and by doing so, pave the way for future
development and wholistic understanding of treatment options.
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Chapter 2. STRUCTURAL ANALYSIS OF Q10 PEPTIDE FIBRIL POLY-
MORPHS
This section is partially adapted and reproduced (with permission) from the following
manuscript: Punihaole, D.; Workman, R.J.; Hong, Z.; Madura, J.D.; Asher, S.A. The
Journal of Physical Chemistry B. 2016, 120(12), 3012-3026.
2.1 Review of PolyQ Fibril Structure
It is clear that polyQ-rich aggregates play an important role in the pathology
of polyQ diseases such as Huntington’s.6,10,11,72 Given this fact, it is key to under-
stand the structure of polyQ-rich aggregates; information that may aid researchers
in inhibiting or reversing the aggregation process. A simple diagram of polyQ fibril
formation is depicted in Figure 2.1.
Numerous studies of the structure of polyQ fibrils have been published using
a plethora of biophysical analytical methods.8,12,17,20,24–38 In 1994, Perutz et al.20
reported one of the earliest investigations of polyQ fibril structure, examining the
structure of D2Q15K2 peptide fibrils. The aspartate and lysine amino acid pairs at
the termini of this peptide enable solubility in water. Residues with charged side
chains are now commonly appended to glutamine repeat peptides for this reason.
Perutz and coworkers observed peptide aggregates with a wide range of molecular
weights with size exclusion chromatography assays.20 They used circular dichroism
spectroscopy (CD) to probe the secondary structure of solutions of the D2Q15K2
peptides. CD spectra for these samples were uniformly indicative of β-sheets; this
was the first out of many studies that would confirm that polyQ peptides form β-
sheet aggregates and fibrils that are similar to those formed in amyloid diseases such
as Alzheimer’s and Parkinson’s.6,20,31,36,37
X-ray diffraction studies have shown that polyQ fibrils of various glutamine re-
peat lengths all possess similar diffraction patterns.36,37 However, the authors of these
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Figure 2.1: Simple schematic of polyQ aggregation. Aqueous monomeric peptides
associate to form ordered aggregates which eventually form mature insoluble fibrils
in the neuron (shown in a electron micrograph). Source: figure prepared with Adobe
Illustrator.
reports have assigned very different structures from relatively similar diffraction pat-
terns. Perutz et al.20,28 concluded that X-ray diffraction data for a variety of amyloid
fibrils, D2Q15K2 fibrils included, are consistent with water-filled β-nanotubes stabi-
lized by side chain interdigitation, a phenomenon that has been termed a “polar”
or “steric” zipper. Zipper interactions in a pair of stacked β-sheets are shown in
Figure 2.2.
Figure 2.2: β-sheets forming side chain zipper. Source: figure prepared with VMD.83
Sikorski et al.36 analyzed the structure of D2Q15K2 fibrils and disagreed with
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Perutz et al.,28 concluding that these fibrils are composed of antiparallel β-sheets
with a β-hairpin as the monomeric unit. Sharma et al.,37 in an X-ray diffraction
study of Q8, Q15, Q28, and Q45 fibrils, found that all four peptides formed slab-like
antiparallel β-sheets made up of β-hairpins as opposed to β-nanotubes, agreeing with
Sikorski’s conclusion.
A few more recent structural analyses of polyQ fibril aggregates were carried
out with solid-state NMR spectroscopy. One such study29 found that polyQ fibrils
composed of physiologically relevant glutamine repeat lengths, i.e. QN>37, form an
antiparallel β-sheet structure dubbed a “β-arc”. Example β-arc and β-hairpin peptide
structures are depicted in Figure 2.3.
(b)
(a)
Figure 2.3: Two polyQ structures proposed to make up fibrils: (a) β-arc and (b)
β-hairpin. Source: figure prepared with VMD.83
In β-arc fibril structures, individual peptides occupy multiple layers of β-sheets,
similar to fibril structures for the Alzheimer’s Aβ protein reported by Petkova and
others.84 It is worth noting that all other instances of β-arc fibril structures were
observed to be parallel β-sheets, which is not the case in polyQ studies. Geometri-
cal differences between antiparallel and parallel β-sheets are depicted in Figure 2.4.
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Antiparallel β-sheets (shown on the left in Figure 2.4) form linear amide-amide H-
bonds, where parallel β-sheets (right side of Figure 2.4) form staggered amide-amide
H-bonds. In antiparallel β-sheets, the Ψ,Φ dihedral angles of the backbone cause the
structure to be slightly lower in energy.85
Antiparallel -sheet Parallel -sheet
(Φ,Ψ) ≈ (–135, 135) (Φ,Ψ) ≈ (–120, 125)
Figure 2.4: Geometries of antiparallel and parallel β-sheets. Average (Φ,Ψ) angles
for each type of β-sheet are shown. Source: figure prepared with VMD83 and Adobe
Illustrator.
However, other solid-state NMR work suggests alternative structural motifs; Sivanan-
dam et al.86 observed NMR data consistent with β-sheets formed of β-hairpin monomers,
and kinetics work by Kar et al.13,30 asserts that β-hairpin turns are critical to the ag-
gregation kinetics of Q23 and Q26 peptides, although this does not directly correspond
to the presence of β-hairpins in large fibril aggregates.
MD simulation approaches have been utilized in recent years to investigate the
structural properties of polyQ-rich fibrils[23, 82]. Most of these computational stud-
ies probe the kinetic or thermodynamic stability of different types of fibril structures
posited by past experimental observations. Work by Esposito et al.,23 found that
Q15 is stable in extended, antiparallel β-sheets and side chain zippers play an im-
portant role in stabilizing, but not forming, the fibrils. Another study82 found that
among β-sheet motifs for short polyQ peptides, antiparallel β-sheets form more sta-
ble fibrils than parallel β-sheets. However, the majority of these studies are carried
out independent of experimental considerations, and as a result direct comparison of
computational and experimental findings is rare.
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Overall, there is a lack of consensus regarding the structural properties of polyQ
peptide fibrils; this serves to underscore the need for incisive and reliable biophysical
methods that can discriminate between the myriad of proposed polyQ fibril models in
a quantitative, clear way. One main component of understanding the structural be-
havior of polyQ fibrils is characterizing the conformations and H-bonding interactions
of glutamine side chains, which have been reported by many of the aforementioned
polyQ studies to play a crucial role in the stability and selectivity of polyQ struc-
tures. There is also uncertainty in the field as to the type of β-sheets that these
peptides form.20,29,36,37,87 As mentioned earlier, other amyloidogenic fibrils form pri-
marily parallel β-sheets.6,84 However, there have been numerous reports of polyQ
fibrils forming antiparallel β-sheets instead.20,36,37 This is an important distinction,
because currently, polyQ fibrils are categorized under the larger umbrella of amyloid
fibrils. If the structure of polyQ fibrils is fundamentally different than these other
types of fibrils in the type of β-sheet that forms, this may serve as an important
distinction between the groups of fibril diseases.
2.2 MD Simulations and UVRR Experiments on Q10 Fibrils
In this work, MD simulations and UVRR experiments are coupled to determine the
structure properties of polyQ fibrils prepared from D2Q10K2 (Q10) peptides. Previ-
ously, Xiong et al.25 observed that this peptide can adopt two conformational states
in aqueous solution, a hypothesized β-hairpin-like structure prepared from powder
peptide samples (called NDQ10) and a PPII-rich conformation prepared by disag-
gregating Q10 fibrils (called DQ10). Both of these structural states are shown to
aggregate into amyloid-like fibrils.
UVRR spectroscopy is used here to measure the backbone Ψ dihedral angle dis-
tributions of fibril solutions formed from the NDQ10 and DQ10 monomeric states,
as well as the χ3 side chain dihedral angles. Figure 2.5 shows a visual description
of these two dihedral angles, as well as the Φ dihedral angle. Distributions of these
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Figure 2.5: Atomic visualization of peptide backbone and side chain dihedral angles
(left). On the right is an illustration of the Ψ-dependent NH-CαH coupling possible
in the peptide backbone. Source: figure prepared with VMD83 and Adobe Illustrator.
dihedral angles are quantitatively compared to Ψ and χ3 angle distributions gathered
from MD simulations of three fibril models.
The three Q10 fibril models (shown in Figure 2.6) simulated in this work were
an antiparallel extended β-sheet (Model a), a parallel extended β-sheet (Model b),
and an antiparallel β-hairpin β-sheet (Model c). These systems contained eight Q10
peptides that were assembled into parallel or antiparallel fibril structures. To begin,
two single β-sheets made up of four peptides were constructed. One β-sheet was then
flipped 180◦ so that each strand was oriented in the opposite direction of the peptides
in the other β-sheet. The flipped β-sheet was then stacked on top of the other sheet
to form a stacked β-sheet structure. Rotation of one β-sheet was necessary to ensure
the positively charged termini of one β-sheet were aligned with the negatively charged
termini of the other. Canonical (Φ, Ψ) angles of (−140◦, 135◦) were used to create the
antiparallel β-strands in Model a, and angles of (−120◦, 113◦) were used to make the
parallel strands in Model b. Model c was made using β-hairpin geometries that had
been observed in previous unpublished work by the Madura group.34 All model fibrils
were constructed with the Molecular Operating Environment88 (MOE) software suite
and Visual Molecular Dynamics83 (VMD).
Each eight-peptide fibril model was solvated in a periodic 70× 50× 50 A˚3 water
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Figure 2.6: Octameric Q10 fibril models simulated in Chapter 2. Model a is an
antiparallel extended β-sheet, Model b an extended parallel β-sheet, and Model c a
β-hairpin-sheet. Each model composed of two stacked β-sheets with four peptides
per sheet. Source: figure prepared with Chimera and Adobe Illustrator.
box of 5087 water molecules and energy minimized for 10 000 steps using the conju-
gate gradient minimization method.43 The three systems were then equilibrated at
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constant pressure and temperature for 50 ps. During this minimization and equili-
bration, the x, y, z positions of all the protein atoms of the fibrils were restrained by
a harmonic 1
2
k(x − x0)2 potential. Following this equilibration, restraints were ap-
plied only to the positions of the backbone (O−C−Cα−N) atoms of the peptides, and
another 10 000 steps of minimization and 100 ps of equilibration at constant pressure
and temperature were carried out. The aim of this protocol of restrained minimiza-
tion and equilibration is to allow the water in the system to find the lowest energy
configuration around the fibril structures before the peptides are allowed to freely
move. After this protocol was completed for each system, 50 ns of completely unre-
strained equilibration (no harmonic constraints) was simulated, followed by 200 ns of
data production MD.
The NAMD43 software package (Version 2.10) was used to simulate MD in this
work. Potential energies and forces were obtained with the CHARMM3650 force field.
CHARMM36 was selected for its torsional energy corrections intended to decrease
an α-helix bias previously associated with CHARMM and properly stabilize β-strand
conformations.89 Alternate force fields such as Amber99ffSB56 also include the CMAP
corrections, but CHARMM22 was chosen due to its reported ability to describe α-
helical, β-sheet, and random coil structures accurately.89
The TIP3P90 water model was used to simulate water in all simulations, along
with the particle mesh Ewald algorithm91 for full-system electrostatics with a grid
spacing of 1.0 A˚. The Verlet velocity algorithm45 was used to integrate the equations
of motion with a time step of 2 fs. All simulations were performed under constant
pressure and temperature (NPT) with a Langevin thermostat and piston utilized to
maintain a temperature of 300 K and pressure of 1.013 25 bar respectively.43,92 A pair
interaction cutoff of 12.0 A˚ was used with a nonbonded switching distance of 10.0 A˚.
Analysis was performed with Visual Molecular Dynamics83 (VMD) and its native
Tcl scripting. Ψ and χ3 dihedral angles were collected from all glutamine residues with
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a Tcl script in VMD.83 χ3 side chain dihedral angles were only taken from glutamine
side chains that were in the buried interior of the fibril models, to best simulate the
interior of a bulk fibril environment. Extent of dissociation for the fibril models was
determined by visual inspection of the structures along with an RMSD metric for the
fibril structure calculated with respect to the backbone atoms of the peptides. The
Gibbs free energy difference, ∆G, between Models a and b was calculated using a
Python implementation of the Bennett acceptance ratio called Pymbar.93 Potential
energies were extracted from NAMD43 log files and used as input for Pymbar.
H-bonding analysis was performed on Models a and b using VMD.83 Positive H-
bond contacts were specified as a heavy atom (N-O) distance of <3.0 A˚ and an N-H-O
angle between −30◦ and 30◦. Backbone-backbone, backbone-side chain, side chain-
side chain, and peptide-water H-bond populations were calculated over the course of
each 200 ns trajectory. Histograms of these data were prepared with the statistical
computing package R.94
2.3 Analysis of the Structural Properties of Q10 Fibril Polymorphs
The 200 ns MD simulations of the computational fibril Models a, b, and c indicate
that the extended β-sheet fibrils, Models a and b, are significantly more stable than
the β-hairpin composed fibril. Figure 2.7a-c shows the structure of each fibril model
at 50 ns intervals throughout the simulations. Panel 2.7c shows the dissociation of
the β-hairpin fibril model, which occurs at roughly 60 ns into the 200 ns production
simulation. Models a and b, depicted in 2.5a,b, remain structurally intact throughout
the entire simulation. The RMSD of the backbone atoms of each fibril model was
recorded with respect to the initial structure; Figure 2.8 shows the progression of the
RMSD traces for each model. An RMSD value of 3.0 A˚ was defined as the cutoff
for dissociation, as visually the fibril structure of the β-hairpin fibril began to break
apart above this level.
The results from these simulations indicate that Q10 does not form stable β-
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Figure 2.7: Snapshots from the 200 ns MD trajectory of three 8-mer Q10 fibrils.
Structures were solvated but water was not shown for purposes of illustration. Source:
figure prepared with Chimera and Adobe Illustrator.
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Figure 2.8: Plot of RMSD vs. time for the three Q10 fibril polymorphs. RMSD
taken with respect to α-carbons of initial structure. Source: figure prepared with
Python package Matplotlib.
hairpin fibrils.
To couple computational and experimental observations of the structure of Q10
fibrils, backbone Ψ dihedral angle distributions were calculated from each method
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and compared and contrasted. Figure 2.9 shows the Ψ distributions from both the
experiments and computations.
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Figure 2.9: Comparison of Ψ dihedral angle distributions for three Q10 fibril poly-
morphs from MD simulations and UVRR spectra. Canonical locations of parallel and
antiparallel β-strand structure shown with dotted red line. Source: figure prepared
with Python package Matplotlib and Adobe Illustrator.
Panels 2.9a,b show UVRR data from fibrils prepared from the NDQ10 and DQ10
monomeric conformational states. Both distributions feature prominent peaks at 145◦
in the antiparallel β-strand region, as well as a smaller shoulder located at around
125◦, which corresponds to a minor population of parallel β-strand. The nearly iden-
tical nature of these distributions indicates that both NDQ10 and DQ10 form the
same fibril structure. In Panels 2.9c-e Ψ distributions from the data production MD
simulations of computational fibril Models a, b, and c are displayed. Distributions
for Models a and b have large peaks at ∼141◦ and ∼127◦ respectively, which closely
correspond to the locations of the experimentally observed peaks of 145◦ and 125◦
for antiparallel and parallel β-sheet populations. Model c yielded a distribution pos-
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sessing a doublet at ∼−19◦ and ∼−43◦ that is not observed in the experimental
distributions. This feature is indicative of the i + 1 and i + 2 residues of the type
I β-turn present in the β-hairpins of Model c. The agreement between the β distri-
butions for Models a and b and those obtained from UVRR supports the conclusion
that the structural motif for NDQ10 and DQ10 peptide fibrils are stacked β-sheets
made up of extended β-strands.
Moreover, these models are consistent with the results from other polyQ work.
Schneider et al.29 posited, based on EM and solid-state NMR data, that D2Q15K2
peptide fibrils consist of extended β-strands. Another study by Thakur and others27
found that polyQ peptides with β-hairpin-inducing proline-glycine moieties only form
stable β-sheet fibrils when each side of the β-hairpin contains stretches of at least 9-
10 glutamine residues. The D2Q10K2 peptides studied here would not be capable of
forming β-hairpin fibrils based on that criterion. This strengthens our conclusion that
Q10 fibrils are composed of extended strands rather than hairpins.
The next question we looked to address was whether Q10 adopts parallel or an-
tiparallel β-sheets. Most amyloid fibrils form parallel β-sheets, which seem to max-
imize hydrophobic and steric zipper interactions. PolyQ fibrils are relatively unique
among amyloid fibrils if they form antiparallel β-sheets, which many studies suggest
they do.36,37 To examine the preference between antiparallel and parallel β-sheets in
polyQ fibrils, we used the Bennett acceptance ratio method93 to calculate the free
energy difference between fibril Models a and b. The free energy of the antiparallel
β-sheet fibril system, Model a, was found to be 160.5± 2.0 kJ mol−1 lower than the
parallel β-sheet model, Model b. Because the fibrils were composed of eight Q10
peptides, we were able to infer that the free energy difference between Models a and
b was ∼1.5 kJ mol−1 per peptide bond. These results provide further confirmation
that antiparallel β-sheet formation is favored in polyQ fibrils and accounts for the
greater fraction of Q10 antiparallel β-sheet observed in the experimental results. Our
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collaborators were able integrate the amide vibrational bands in the UVRR spec-
tra to estimate an analogous free energy difference per peptide bond for antiparallel
and parallel Q10 fibrils. This yielded a free energy difference per peptide bond of
∼1.0 kJ mol−1, which corresponds well to the value obtained from simulation.
We investigated the electrostatic and H-bonding interactions of Models a and b
to probe the cause of the energy favorability of antiparallel over parallel polyQ β-
sheets. Electrostatically, Models a and b possess favorable interactions between the
N-terminal aspartate residues and C-terminal lysine residues from opposing stacked
β-sheets. Within the β-sheet, we found that Model a features favorable inter-sheet
Coulombic interactions between oppositely charged terminal residues. However, the
parallel β-sheet of Model b does not allow these inter-sheet opposite charge termi-
nal interactions and like-charged terminal interactions destabilizes the fibril. This
repulsion between the terminal residues in parallel Q10 β-sheets may perturb local
backbone-backbone H-bonding.
Another quantitative marker we used to compare our MD simulations to our
collaborator’s experiment in this work was the χ3 side chain dihedral angle (Cβ-Cγ-
Cδ-O). Distributions for χ3 can be calculated from UVRR spectra in the same way
as the Ψ angle because the side chain amide possesses the same structural sensitivity
as the backbone amide.
Figure 2.10 is organized the same way as Figure 2.9, showing χ3 dihedral angle
distributions for the NDQ10 and DQ10 structural states in Panels 2.10a and b, and
distributions from the simulations of Models a, b, and c in Panels c-e. The experimen-
tal χ3 distributions in Panels a and b are similar, featuring two Gaussian populations
of angles centered around −14◦ and 5◦ for NDQ10 and −12◦ and 3◦ for DQ10. For
the computational results, the antiparallel β-sheet Model a has a salient peak at 4◦
and the parallel β-sheet Model b gives a distribution with a dominant peak centered
at −10◦. Each of these peaks correspond well to the distributions obtained from the
29
-150 -100 -50 0 50 100 150
χ3 dihedral angle (°)
-150 -100 -50 0 50 100 150
χ3 dihedral angle (°)
0
0.2
0.4
0
0.2
0.4 antiparallel β-sheet (a)
parallel β-sheet (b)
Pr
ob
ab
ilit
y
NDQ10 fibrils
DQ10 fibrils
3=3°3=–12°
3=–14° 3=5°
MDUVRR
Figure 2.10: Comparison of χ3 side chain dihedral angle distributions for the an-
tiparallel and parallel β-sheet Q10 fibril polymorphs from MD simulations and UVRR
spectra. Source: figure prepared with Python package Matplotlib and Adobe Illus-
trator.
UVRR spectra of NDQ10 and DQ10.
These results shed light on the structure of glutamine side chains in polyQ fibrils.
Both computation and experiment report χ3 side chain dihedral angles centered close
to 0◦. Figure 2.11 shows the orientation of interdigitated glutamine side chains in
the fibril Models a and b. One can observe that the side chains are approximately
planar in orientation. This planarity allows the side chains from opposing stacked β-
sheets to tightly interdigitate, forming the hallmark steric zipper. Interestingly, this
conformation also enables the primary amide groups on the side chains to accept and
donate H-bonds between the side chains on adjacent β-strands, forming an organized
network of H-bonds. This is the first analysis of polyQ fibril side chain structure that
predicts the side chain zipper interactions that have been abundantly reported in the
literature.
2.4 Conclusions and Direction
In this study, we performed a detailed structural analysis of fibrils formed from
two conformational states of Q10 using MD paired with UVRR spectroscopy. Analy-
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Figure 2.11: Illustration of planar side chain H-bonding network. Side chains from
top and bottom β-sheets form tightly packed cores. Source: figure prepared with
Matplotlib and Adobe Illustrator.
sis and comparison of Ψ dihedral angle distributions, as well as analysis of structures
from the MD simulations led us to conclude that Q10 fibrils are composed of ex-
tended β-strands, rather than β-hairpin structures proposed in the literature. The
predominant type of structure observed in Q10 fibrils is an ordered antiparallel β-
sheet. Computational free energy calculations showed that antiparallel β-sheets are
significantly lower in free energy than parallel β-sheets. This is an important finding
that helps explain why polyQ fibrils prefer antiparallel configurations, in contrast
to most types of amyloid fibrils. We performed a H-bonding analysis of antiparallel
and parallel β-sheet fibril models that indicates that the favorability of antiparallel
structures arises from H-bonding, particularly the formation of a greater number of
favorable backbone-backbone H-bonds by antiparallel β-sheets. Finally, analysis of
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distributions of the χ3 side chain dihedral angle definitely showed that Q10 side chains
prefer to form planar conformations that can tightly interdigitate, which gives rise to
the steric zipper interactions that stabilize polyQ fibrils.
This investigation of Q10 fibril structure has shown that, for short polyQ pep-
tides, extended antiparallel β-sheets are the predominant structural motif in polyQ
fibrils. The impact of this discovery lies in the understanding of the aggregation
mechanism for Q10, and we have shown that the aggregation mechanism must lead
to the formation of extended antiparallel β-sheets rather than β-hairpin fibrils. A
remaining question was the monomeric phenomenon that lead to the aggregation and
fibril formation of Q10. Xiong et al.25 had shown that Q10 can adopt two distinct
conformational states as an aqueous monomer. The next step in this dissertation was
to develop a molecular picture of these monomeric states for Q10 to better elucidate
beginning steps of the aggregation process depicted in Figure 1.3.
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Chapter 3. CALCULATION AND EXPLORATION OF THEMONOMERIC
CONFORMATIONAL ENERGY LANDSCAPE OF Q10 PEPTIDES
This section is partially adapted and reproduced (with permission) from the following
manuscript: Punihaole, D.; Jakubek, R.S.; Workman, R.J.; Marbella, L.E.; Camp-
bell, P.; Madura, J.D.; Asher, S.A. The Journal of Physical Chemistry B. 2017,
121(24), 5953-5967.
3.1 Review of Aqueous PolyQ Monomeric Structure
All nine known polyQ diseases are caused by elongated CAG codon repeats that
encode expanded polyQ tracts in proteins.10,11 In these diseases, expanded polyQ
protein tracts are the only shared commonality that links the disease pathologies.13,95
The residue sequences that flank the polyQ repeat sections have been reported to
influence the kinetics of the aggregation mechanism,27,38 but the flanking sequences
vary by polyQ disease yet all display the same molecular pathology. This indicates
that the properties of the polyQ repeat expansions alone are responsible for causing
native proteins to misfold and aggregate into amyloid-like fibrils. Because of this,
investigating the structural tendencies of polyQ peptides can aid in understanding
how these peptides disrupt protein structure and subsequently aggregate. It has been
shown that polyQ aggregates prepared in vitro from model polyQ peptides composed
of only glutamine residues form fibrils that are remarkably similar to those formed
in the brains of polyQ disease patients.8,20 In particular, in vitro fibrils composed
of model QN peptides of varying repeat length share properties such as filamentous
morphologies, binding amyloid markers such as thioflavin-T, and characteristic β-
sheet-rich fibril structures.18,96
Many experimental studies of soluble polyQ peptide structure report that these
peptides adopt structurally disordered conformations.18,75,77,96–98 However alternative
conclusions have been drawn, one such study asserts that polyQ peptides contain
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small sequences of folded structures that are thought to possess cytotoxic qualities.22
In addition, numerous computational investigations of these peptides have reported
conflicting structural propensities.19,76,99–101 For example, Singh et al.99 report that
polyQ peptides resist collapse and exist in primarily extended conformations, while
studies by Wang et al.76 and Vitalis et al.19 observe collapsed disordered structures
that are poorly hydrated. One thing that all studies echo is the lack of regular
secondary structures in monomeric polyQ, with only transient portions of β-helices,
β-sheets, or β-turns.
An important distinction to be made here is that, although polyQ peptides are
thought to have disordered structures, most studies do not report behavior indicative
of a true random coil polymer. A number of studies find that end-to-end distances
of polyQ peptides differ significantly from random coil models in that they favor
collapsed conformations, where a random coil has no preference.76,77,99–101 One exper-
imental study used CD and NMR to show that short polyQ sequences have a high
propensity to form polyproline II-like (PPII-like) structures.98
A variety of key questions about polyQ monomeric structure elude the field. For
example, and of critical importance in this dissertation, the behavior of these pep-
tides that leads to fibril nucleation and growth is not understood. Chen et al.96
have proposed that fibril nucleation is triggered by an unfavorable conversion from
random coil structure to β-sheet. Alternatively, work by Vitalis et al.19,77 posits
that oligomers of these peptides form disordered, globular aggregates that undergo a
structural conversion into ordered β-sheet fibrils.
Gaining a detailed understanding of the conformational ensemble that governs the
monomeric structural tendencies of polyQ peptides would provide insight that could
illuminate many current discrepancies in the field. PolyQ monomeric structure is key
to characterizing the initial steps of the aggregation process (top row in Figure 1.3), as
monomeric conformations adopted by polyQ peptides will determine the association
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events that induce aggregation (middle and bottom rows of Figure 1.3). Many of
the contradictions and disagreements concerning monomeric polyQ structure arise
from the limitations of the standard biophysical analysis techniques used to study
these systems. A validated pairing of multiple analysis techniques, optimally both
experimental and computational, is desired.
3.2 MD Simulations and UVRR Spectroscopy of Aqueous Q10 Monomers
In this dissertation, we characterized the structural ensemble of monomer D2Q10K2
(Q10) peptides using an approach that synergistically utilizes MD simulations and
UVRR spectroscopy. This work built upon initial observations made by Xiong et al.25
We performed an in silico quantification and exploration of the conformational free
energy landscape for Q10 using metadynamics MD simulations. Structures populating
local and global minima on this energy landscape were extracted from the simulation
data for further study. As in Chapter 2, backbone Ψ and side chain χ3 dihedral angles
were calculated for these structures, and the resultant distributions were compared
to analogous distributions obtained from UVRR experiments of Q10 monomers. A
detailed H-bonding characterization of the different monomeric structural states was
performed using the simulation data.
Metadynamics MD simulations43,66 were employed to calculate and characterize
the Q10 conformational free energy landscape. The initial molecular structure for
Q10 simulated here was a fully extended peptide with (Φ, Ψ) backbone dihedral an-
gles of 180◦. This peptide was solvated with 6681 water molecules to create a periodic
simulation box with dimensions of 60 × 60 × 60 A˚3. This initial system was energy
minimized for 10 000 steps using the conjugate gradient minimization scheme, fol-
lowed by 50 ps of equilibration under constant temperature and pressure of 300 K and
1.013 25 bar. After equilibration, metadynamics MD simulations43,66 were performed
for a total of 1 µs. Data from these simulations was used to construct the free energy
landscape shown in Figure 3.2.
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The TIP3P90 water model was used to model water in all simulations, along
with the particle mesh Ewald algorithm91 for full-system electrostatics with a grid
spacing of 1.0 A˚. The Verlet velocity algorithm45 was used to integrate the equations
of motion with a time step of 2 fs. All simulations were performed under constant
pressure and temperature (NPT) with a Langevin thermostat92 and piston92 utilized
to maintain a temperature of 300 K and pressure of 1.013 25 bar respectively. A pair
interaction cutoff of 12.0 A˚ was used with a nonbonded switching distance of 10.0 A˚.
All simulation analysis was performed with the VMD83 software package.
To specify the configurational phase space for the energy landscape, we used
three RMSD collective variables that reported the conformation of the Q10 α-carbons
relative to three idealized structures: α-helix, α-hairpin, and PPII-helix. The α-helix
and PPII structures were created using MOE software,88 and the β-hairpin was taken
from previous Q10 MD simulations. A maximum RMSD value of 12.0 A˚ was used and
this upper limit was maintained with a harmonic potential of the form 1
2
k(x−x0)2 with
a force constant, k, of 1.0 kcal mol−1. This approach for calculating the conformational
energy landscape was employed by Gaborek et al.102 previously.
In the metadynamics simulation, Gaussian energy functions of height∼1.0 kcal mol−1
and width 3.0 A˚ were added to the energy landscape every 500 steps66 (see Equa-
tion 1.10). Low energy structures were extracted from the metadynamics simulation
based on their RMSD values and the history of deposited Gaussians. More Gaussians
deposited at a certain conformation correspond to a lower energy structure. These
low energy structures were simulated using standard MD without metadynamics for
10 ns to collect equilibrium statistics. The H-bonding present in these trajectories
was then analyzed using the H-bonding module in VMD.83 A heavy atom distance
of <3.5 A˚ and H-bond angles of 180± 30◦ were used to determine the presence of
a H-bond. Φ and Ψ backbone dihedral angles were gathered from the simulation
trajectory with a Tcl script in VMD. Free energy output from the metadynamics
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calculation and associated RMSD collective variable values were processed with two
Python scripts, and the R statistical computing package was used to plot the energy
landscape.94
Constrained MD simulations were used to evaluate the potential energy of Q10
in PPII and 2.51-helix conformations, constructed with (Φ, Ψ) angles of (−75◦, 150◦)
and (−130◦, 177◦) respectively. In these simulations, constraints were imposed on the
Φ and Ψ dihedrals angles with NAMD.43 This caused the 2.51-helix and PPII peptides
to keep their secondary structures throughout the simulations. 0.25 kcal mol−1 A˚
−1
force constants were placed on the dihedral angles with the Collective Variables mod-
ule in NAMD.43 In the constrained simulations, solvated Q10 systems were energy
minimized for 10 000 steps using the conjugate gradient method,43 followed by 1 ns
of equilibration. Data collection MD runs of 200 ns were then carried out. Potential
energies were obtained with the NAMD Energy module.43 Stretching, bending, tor-
sional, van der Waals, and Coulombic energies were computed for every frame of the
coordinate trajectory files and averaged using a Python script. H-bonding analysis
of the trajectories was performed with VMD’s Hydrogen Bond tool.
3.3 Characterization of the Monomeric Q10 Conformational Ensemble
UVRR spectra of the NDQ10 and DQ10 peptide samples shows that DQ10 pop-
ulates a structural state that is PPII-rich. This state also has a Ψ angle distribution
with a peak at 170◦, which is not a common region for Ψ angles to occupy.103 Xiong et
al. observed this peak previously and structure resulting from this has been deemed
a 2.51 helix.
25 Both PPII and 2.51-helix represent extended structures, so the DQ10
state can be characterized as an extended state rich in PPII-helix and featuring a
fraction of 2.51-helix. NDQ10 on the other hand has a clean Ψ angle distribution
with a large peak centered around 140◦ which corresponds to β-strand type struc-
ture. The Ψ angle distributions from the UVRR experiments are shown in Panels a
and c of Figure 3.1.
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Figure 3.1: Distributions for peptide Ψ and χ3 dihedral angles from MD simulations
and UVRR experiments. Panels a and c show UVRR-obtained Ψ angles for DQ10
and NDQ10 peptide samples, and panels b and d show MD-calculated Ψ distributions
for states B (collapse β-strand) and A (PPII). The right side shows χ3 distributions
organized the same as the right side. Source: figure prepared with Python package
Matplotlib and Adobe Illustrator.
Data from the metadynamics MD simulations was used to gain insight into the
relative energies of the Q10 structural, as well as the activation barrier between the
DQ10 and NDQ10 monomer states. Figure 3.2 shows the conformational Gibbs free
energy landscape of Q10 as a function of three collective variables, defined as RMSD
comparisons to three idealized structures: α-helix, β-hairpin, and PPII. These were
chosen because they are common structural motifs that enable one to distinguish
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clearly between possible Q10 conformations. Additionally, a β-hairpin structure was
used as this structure has been implicated as a possible aggregation nucleus.30,74
We observe that the conformational free energy landscape of Q10 is rugged and
frustrated, as it contains a many relatively shallow local minima. However, four
deep free energy minima (dark purple areas on Figure 3.2) were identified. The
energy minima contain different structural states (A-D) that are defined both by their
backbone dihedral angles (Figure 3.3) and their H-bonding properties (Figure 3.4).
The structures populating State A possess backbones with average (Φ, Ψ) an-
gles of (−90◦, 140◦), in the region of a β-strand-like conformation (Figure 3.3a).
These conformations are referred to as “collapsed” β-strands, instead of β-hairpins,
because they lack the backbone amide H-bonding patterns that define canonical β-
hairpins. As evidenced in Figure 3.4, these β-strand structures form, on average,
more side chain↔backbone H-bonds than the other monomeric states. These side
chain↔backbone H-bonds, together with the attractive charge-charge interactions
between the aspartate and lysine residues, cause the β-strands to adopt compact
(“collapsed”) conformations.
The (Φ, Ψ) angle distribution for State B has a strong population at about (−80◦,
150◦), which is indicative of PPII secondary structure (Figure 3.3b). A minority
of Ramachandran angles, located around (−50◦, −57◦), indicate that State B also
contains β-turn-like conformations. Viewed together, these two populations of (Φ,
Ψ) angles imply that State B is made up of structures containing short PPII helices
broken up by turns or bends. Our H-bonding analysis of this state (Figure 3.4)
indicates that, compared to State A, both the backbone and side chains of State B
are preferentially hydrated by peptide↔water H-bonds.
The structures that reside in State C have backbone (Φ, Ψ) angles centered at
(−135◦, 135◦), characteristic of β-strand structures (Figure 3.3c). A minor popula-
tion adopts type I’ β-turn angles (−40◦, −85◦). In contrast to State A’s collapsed
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Figure 3.2: Conformational energy landscape for monomeric Q10 from metady-
namics MD simulations. The lowest energy states are represented by the dark violet
isosurfaces with example structural states shown. Source: figure prepared with R94
and Adobe Illustrator.
β-strand structures, β-hairpin structures found in State C form more intrapeptide
backbone↔backbone H-bonds(Figure 3.4c). These backbone H-bonds are indicative
of canonical β-hairpin secondary strutures, as defined by Milner et al.104 Additionally,
the side chains of these β-hairpins are more solvated by H-bonds to water than those
of the collapsed β-strand structures populating State A (Figure 3.4a).
The Q10 conformations located in State D are α-helical conformations. As shown
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Figure 3.3: (Φ,Ψ) dihedral angle distributions for the (a) collapsed β-strand struc-
tures from State A, (b) PPII structures from State B, (c) β-hairpin structures from
State C, and (d) α-helix structures from State D. Panel (e) shows (Φ,Ψ) angles of
terminal aspartate and lysine residues from State B while (f) shows (Φ,Ψ) angles from
all glutamine residues from State B. Source: figure prepared with Python package
Matplotlib and Adobe Illustrator.
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in Figure 3.3e, the (Φ, Ψ) angles are distributed uniformly (−50◦, −65◦). This struc-
tural state possesses a large amount of backbone↔backbone H-bonding (Figure 3.4c),
as expected for α-helix secondary structure, while the side chains remain well solvated.
The collapsed β-strand (State A) occupies the global minimum in the confor-
mational free energy landscape, while the PPII-rich (State B), β-hairpin (State C),
and α-helix (State D) states occur at 0.5, 0.66, and 1.0 kcal mol−1 higher in energy,
respectively. A 3 kcal mol−1 to 6 kcal mol−1 energy barrier separates states A from
state B. Both states C and D are isolated from all other states by a 6 kcal mol−1 to
15 kcal mol−1 energy barrier.
Our analysis of the backbone Ψ and Φ data for States A-D (Figure 3.3a-d) con-
cludes that State A (collapsed β-strand) and State B (PPII-like) structures correspond
to the UVRR measured NDQ10 and DQ10 monomers, respectively. To validate the
simulation observations, the UVRR measured Ψ and χ3 angle distributions of DQ10
and NDQ10 were compared to the distributions calculated from the Q10 structures
populating the A and B structural states (Figure 3.1). Agreement between the ex-
perimental and simulation Ψ angle distributions is excellent. However, the χ3 angle
distributions for the side chains taken from the MD simulation data agrees poorly
with the UVRR distributions.
Figure 3.1a-d compares Ψ distributions of States A and B from the metadynamics
simulations to those of experimental DQ10 and NDQ10. The corresponding Ψ angle
distributions are in good qualitative and quantitative agreement. The only signifi-
cant discrepancy is that the distribution for State B (Figure 3.1b) lacks a peak at
∼175◦ that corresponds to experimentally observed 2.51-helix conformations. This
incongruence is discussed in detail later.
The χ3 distributions for states A and B calculated from the metadynamics trajec-
tories are bimodal (Figure 3.1f,h). Both distributions have large peaks around ∼−70◦
and ∼110◦. These χ3 angles do not agree with those measured by UVRR. The side
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chain rotamer database by Dunbrack et al.105 reports that glutamine residues nor-
mally possess χ3 angles distributed between ∼−90◦ and 90◦, inconsistent with the
distributions shown in Figure 3.1f,h.
We suspect that the disparity between our MD simulated χ3 angle distributions
and those calculated from the UVRR data stems from the lack of parametrization
for non-rotameric side chain dihedrals in the CHARMM36 force field.50 Best et al.106
document how the χ1 and χ2 dihedral angles of various side chains were parameterized
in CHARMM36 using experimental data. However, to our knowledge, non-rotameric
side chain dihedral angles, such as the χ3 angle of glutamine, have not been similarly
optimized in CHARMM36.106
We compared the backbone and side chain H-bonding populations present in the
metadynamics structural states (Figure 3.4).
Figure 3.4: Depicted here are H-bonding populations for the four structural minima
identified in Figure 3.3. Only amide-amide or amide-water H-bonds were considered.
Source: figure prepared with Python package Matplotlib and Adobe Illustrator.
Our computational results mirror the implications of our experimental findings.
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The State B structures feature primarily peptide↔water H-bonding, while the State
A structures show significant intrapeptide H-bonding.
Our metadynamics data confirm the presence of a significant free energy activation
barrier between the PPII (DQ10) and the collapsed β-strand (NDQ10) conformational
states. We calculate an energy barrier of 3-6 kBT separating states A (β-strand) and
B (PPII). The energy barrier region between states A and B also contains ≥8 local en-
ergy minima, with relative energy well depths of ∼1.0 kcal mol−1 (Figure 3.5). These
local minima represent metastable structural states along the energy barrier. Even if
Q10 can surmount the large energy barrier, the kinetics of transition will be impeded
by these energy wells to prevent PPII-like to β-strand structural interconversion.
The UVRR spectra of DQ10 surprisingly features a significant population of the
2.51-helix conformation previously proposed by Krimm and co-workers67. We used
classical MD simulations to more deeply examine the factors that stabilize 2.51-helix
conformations in Q10. We simulated three different Q10 peptide structures. One
structure has its backbone dihedral angles constrained to the canonical 2.51-helix
conformation, the second structure has a PPII conformation, and the third structure
has alternating PPII and 2.51-helix backbone dihedral angles. We identified the over-
all lowest energy structure of each of the constrained simulations. We then calculated,
for each Q10 structure, the energy contributions of bond stretches, bond angle bend-
ing, dihedral angle rotation, electrostatics, and van der Waals to the overall potential
energy of the system (Table 3.1). Neglecting the influence of solvating waters, our
simulations indicate that the potential energy of the 2.51-helix is ∼50 kcal mol−1 lower
than that of the PPII structure, mainly due to intrapeptide electrostatics.
To determine the electrostatic potential energy contributions of the charged ter-
minal residues, we compared the electrostatic energy terms of just the glutamine
residues of Q10 for the 2.51- helix and PPII structures. We find that for glutamine
residues the electrostatic potential energy difference between the 2.51- helix and PPII
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Figure 3.5: Shown is the Q10 monomeric conformational energy landscape with
the energy barrier region between states A and B highlighted. Local energy minima
on the barrier are shown as an orange energy surface, and example local minimum
structures are shown as (a) and (b). Source: figure prepared with VMD,83 R,94 and
Adobe Illustrator.
PPII structure PPII/2.51 structure 2.51 structure
U terms all polyQ all polyQ all polyQ
bond 44± 5 33± 5 44± 5 32± 5 43± 5 32± 5
angle 134± 10 96± 8 134± 10 95± 8 134± 10 96± 8
dihed. 146± 5 107± 4 160± 5 121± 4 174± 6 131± 4
vdW −14± 4 −11± 3 −16± 4 −14± 4 −15± 4 −14± 4
elec. −436± 29 −318± 10 −461± 35 −331± 8 −487± 37 −330± 9
Table 3.1: Contributions (in kcal mol−1) of various types of potential energies to
the total energy of entirely PPII monomeric Q10, partially PPII/2.51-helix Q10, and
entirely 2.51-helix structure. Columns labeled “all” contain potential energies taking
glutamine and terminal residues into account, while columns labeled “polyQ” contain
potential energies calculated just for glutamine residues.
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structures is only ∼10 kcal mol−1. Thus, the charged terminal residues contribute
most heavily to the electrostatic potential energy difference between the PPII and
2.51-helix structures.
We also compared the (Φ, Ψ) angle distributions of the glutamine residues and
the charged flanking residues for State B structures. As shown in Figure 3.3e, the
terminal aspartic acid and lysine residues preferentially adopt (Φ, Ψ) angles centered
roughly at (−115◦, −160◦), closer to the (Φ, Ψ) angles of the canonical 2.51-helix
conformation. In contrast, the glutamine residues (Figure 3.3c) adopt (Φ, Ψ) angles
of (−80◦, −150◦) and (−50◦, −57◦), indicative of PPII and turn-like conformations,
respectively. This suggests that the 2.51-helix-like conformations are selectively lo-
calized to the peptide bonds of the charged terminal residues, while the glutamine
residues occur in a predominately PPII conformation. Our collaborators calculate
that a single DQ10 peptide has 2 residues to 3 residues in a 2.51-helix conformation,
most likely occurring on the terminal residues. However, our MD simulations indicate
that the 2.51-helix-like Ψ angles present in State B are centered around −160◦, closer
to the values for PPII structures than the value of −175◦ measured by the UVRR.
We attribute the discrepancy in the Ψ angle values for the 2.51-helix-like pep-
tide bonds in the simulated State B structures to an inadequacy of the CHARMM36
force field. In the case of CHARMM36, parameters for backbone dihedral angles
are optimized from globular protein X-ray crystal structures and QM data for the
dialanine peptide.55 The 2.51-helix is an uncommon structure that forms in the pres-
ence of adjacent charged amino acids and is unlikely to be well represented in the
X-ray structures used to parametrize CHARMM36. This conclusion is supported by
Liqi Feng, who showed that metadynamics of poly(L-lysine), using the CHARRM36
force field, failed to show a Ψ angle distribution at ∼170◦, indicative of 2.51-helix
conformations.107
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3.4 Discussion and Conclusions
The solution-state structures of polyQ-rich peptides and proteins have been stud-
ied in detail.19,75–77,100,108 Many of the important computational studies were con-
ducted by Pappus group.19,76,77 For example, Wang et al.76 characterized the con-
formational ensemble of N-acetyl-Q5-N’-methylamide (Q5) and N-acetyl- Q15-N’-
methylamide (Q15) that are somewhat similar to our Q10 peptide.
From the MD simulations performed by Wang et al.,76 they conclude that the
conformational energy landscapes of Q5 and Q15 are frustrated, since they observe
numerous metastable and glassy states. Their simulations find essentially no global
energy minimum structures. They show that Q5 and Q15 are structurally disordered
in aqueous solution, with only transient stretches of regular secondary structure ele-
ments, such as PPII-helices, β-strands, and α-helices occurring. They also show that
both Q5 and Q15 peptide bonds have a strong propensity to adopt PPII-like and
α-helix-like (Φ, Ψ) angles.
Wang et al.’s simulations also suggest that structurally disordered, monomeric
polyQ peptides form a significant number of interamide H-bonds, with side chain↔backbone
H-bonding being the most prevalent.76 This is supported by the NMR measurements
by Darnell et al.109 that find that in PPII-rich polyQ peptides the glutamine side
chains adopt “folded-over” conformations that enable H-bonding to the backbone
amides. To our knowledge, this is the only experimental evidence of significant side
chain↔backbone H-bonding in PPII-rich polyQ peptides.
The simulations of Wang et al.76 lead them to hypothesize that the structural
disorder of polyQ peptides stems from the many different possible combinations of in-
tramolecular and intermolecular-amide H-bonds that can form between side chain and
backbone amides. This explains why a β-sheet-rich fibril nucleus13,16 is expected to be
energetically unfavorable. According to their model, the multiple possible combina-
tions of intrapeptide H-bonds promote disorder in the peptide backbone, disrupting
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the formation of backbone↔backbone interactions that enable secondary structures
such as α-helices and β-sheets.
Some aspects of our simulation results are consistent with those of Wang and
coworkers.76 We observe that the conformational energy landscape of Q10 contains
numerous shallow energy minima. Similarly, we observe that Q10 peptides can en-
gage in a large variety of intramolecular side chain↔side chain, backbone↔backbone,
and side chain↔backbone H-bonding interactions. However, there are many aspects
of our results that are inconsistent with their results. For example, our experimental
and metadynamics simulation data reveal that Q10 can adopt stable and well-defined
structural states, with deep energy wells, such as those shown in Figure 3.2. Inter-
estingly, we also find that the side chains and backbone amides of the structurally
“disordered” PPII-rich state of Q10 are predominately H-bonded to water, which
disagrees with the Wang et al. results.76
These disagreements raise two important questions. First, why does Wang et
al.76 not observe any well-defined structural states for small polyQ peptides, whereas
we do? And second, why do the simulations of Wang et al.76 indicate that there
are significant numbers of interamide H-bonds (particularly between the backbone
and side chain amides) in structurally disordered Q5 and Q15 peptides, while our
simulations do not find this for Q10?
To answer the first question, we note that the conformational energy landscape
of polyQ peptides is frustrated, consisting of many local energy wells. Classical MD
simulations generally do not efficiently sample different structural states in these sit-
uations. Thus, one possibility is that the simulated peptides in the Wang et al.76
study are trapped in local energy minima. Our metadynamics calculations enabled
us to sample robustly a greater ensemble of structures than does traditional MD sim-
ulations. Thus, we characterized the entire conformational landscape and discovered
global and local minimum energy conformations.
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We are also aware that the conformational behavior of model polyQ peptides in
solution depends on both the number of glutamine repeats and the choice of non-
glutamine flanking groups. For example, the use of N-acetyl and methylamide flank-
ing groups in Pappu and co-workers’ simulations19,76,77 are better models for polyQ
tracts in proteins. In addition, fluorescence correlation spectroscopy data75 by the
Pappu group and dynamic light scattering data by the Murphy group17 indicate that
structurally disordered long polyQ peptides adopt relatively compact structures in
aqueous solution. These compact structures presumably derive from the fact that
interamide H-bonding interactions become more prevalent and important in polyQ
peptides as the glutamine repeat length increases. For example, Walters and Mur-
phy17 have shown that phosphate buffer is a good solvent for Q8 and Q12, a mediocre
solvent for Q16, and a poor solvent for larger peptides such as Q20. Thus, the model
proposed by Pappu and co-workers in the Wang et al.76 study may be valid in the
limit of polyQ peptides with ≥20 glutamine repeats.
The answer to the second question may lie in the differences of the force field and
water model used by our study compared to the Wang study. As discussed by Wang
et al.,76 the H-bonding interactions observed in a simulation will vary depending on
the force field utilized. Our use of the TIP3P water model and the CHARMM36
modern force field results in different H-bonding interactions compared to that of
the MD simulations of Wang et al.76 The H-bonding interactions predicted by our
metadynamics are in excellent agreement with our UVRR data, which show that our
choice of force field appropriately models the H-bonding interactions in Q10.
The congruence of both our simulation and experimental data gives us confidence
in the relative accuracy and robustness of the CHARMM3650 force field used in this
study. Despite this, we do not dispute the validity of the Pappu et al.’s model to
describe, in general, the underlying physical principles that govern the structural
disorder of larger polyQ peptides or the energetic unfavorability of the coil to β-sheet
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transition.19,76,77 However, we do believe that the importance of side chain↔side
chain and side chain↔backbone interactions in describing the structural disorder of
PPII-rich polyQ peptides may be overstated, at least in the context of small peptide
systems, such as Q5, Q10, and Q15.
In this chapter, we have shown that the monomeric Q10 structural ensemble,
which corresponds to the top row of the aggregation mechanism shown in Figure 1.3,
is made up of two conformational states: a PPII-rich structure and a collapsed β-
strand. These findings are at odds with the right pathway in Figure 1.3 due to the
lack of an accessible β-hairpin structure, and indicate that the leftmost and middle
pathways better describe the Q10 aggregation mechanism.
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Chapter 4. ANALYSIS OF RELATIVE HYDROGEN BONDING STRENGTHS
FOR Q10 PEPTIDES AND FIBRILS
This section is partially adapted and reproduced (with permission) from the follow-
ing manuscript: Punihaole, D.; Jakubek, R.S.; Asher, S.A. The Journal of Physical
Chemistry Letters. 2018, 9(8), 1944-1950.
4.1 Background on the Role of H-bonding in PolyQ Systems
PolyQ peptides contain both primary amides from their glutamine (Q) side chains
and secondary amides from their backbone peptide bonds. Despite the hydrophilic na-
ture of the glutamine side chain, experimental studies indicate that polyQ peptides
with pathologically relevant repeat lengths adopt structurally disordered collapsed
conformations, which suggests that water is acting as a poor solvent.17,18,96–98,110 These
findings are also supported by computational studies,19,76,77,101 which suggest that
polyQ peptides are largely disordered due to the multiplicity of different H-bonding
interactions possible between side chain and backbone amides. Other computational
studies suggest that interamide H-bonds between side chains contribute most signifi-
cantly to the structural stability of polyQ amyloid-like fibrils.111
These and other studies11,32 emphasize the role that glutamine side chain H-
bonding interactions play in dictating the solution-state conformational behavior and
the strong aggregation propensities of polyQ peptides. Surprisingly, no experimental
studies have quantified the relative energetic favorability of side chain versus backbone
amide H-bonding interactions in polyQ peptides. Thus, developing new tools that can
quantify the relative energies of different side chain and backbone H-bonding interac-
tions is important to formulating a more complete, molecular-level understanding of
polyQ fibril formation mechanisms. An important unresolved question to answer in
the field is whether the peptidepeptide H-bonding of polyQ peptides is energetically
stronger that peptidewater interactions.
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4.2 Calculating the Interaction Enthalpy of Q10 H-bonding with MD and
UVRR
Our collaborators developed a method with which to estimate the change in inter-
action enthalpy that occurs when a secondary amide forms different types of H-bonds
relative to the amide in vacuum.35 The frequency of peptide amide vibrational modes,
particularly the secondary amide I (AmIS) band arising from carbonyl stretching,
show sensitivity to the H-bonding environment of peptide amides. Wang et al.112
previously showed that the AmIS frequency is linearly dependent on the solvent ac-
ceptor number, which is a measure of the strength of the H-bonding and van der
Waals interactions of the solvent with the solute. Using this linear correlation, Wang
et al. showed that the AmIS frequency can be used to estimate the change in inter-
action enthalpy (∆Hint) that occurs when a secondary amide is placed into a solvent
environment.
Using this method, ∆Hint values were calculated from UVRR spectra for various
types of side chain H-bonds in Q10 solutions. Several types of H-bonds were calcu-
lated, including side chain↔water H-bonds for the PPII monomeric state (DQ10),
side chain↔backbone and side chain↔water H-bonds for the collapsed β-strand
monomeric state (NDQ10), and side chain↔side chain H-bonds for Q10 fibrils pre-
pared from both the PPII and collapsed β-strand states.
We used MD simulations to calculate analogous ∆Hint values for the same types of
H-bonds. In Chapters 2 and 3, MD simulations of Q10 β-sheet fibrils and monomeric
structures were reported, respectively. In this work, molecular structures from each
of these previous studies were simulated with classical MD, and data from these
trajectories was used to obtain ∆Hint measurements for the H-bonding environments.
From Chapter 2, the antiparallel β-sheet model a was used to calculate H-bonding
enthalpies to compare with the UVRR fibril measurements, and from Figure 3.2 in
Chapter 3, molecular structures for states A and B were used to compare with their
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corresponding experimental structural states NDQ10 and DQ10. The three structures
simulated here are shown in Figure 4.1.
(a)
(b)
(c)
Figure 4.1: (a) Collapsed β-hairpin Q10 monomer (state A from 3), (b) PPII-rich
Q10 monomer (state B from 3), (c) Octameric antiparallel extended β-sheet fibril
(model a from 1). Source: figure prepared with VMD83
Coordinates for Structures a and b from Figure 4.1 were taken from the work
performed in Chapter 3, and Structure c was taken from the Q10 fibril study in
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Chapter 2. Monomeric Structures a and b were previously solvated in 60×60×60 A˚3
periodic water boxes composed of 6681 water molecules. The antiparallel Q10 fibril
structure (Structure c) was solvated in a periodic 70 × 50 × 50 A˚3 water box made
up of 5087 water molecules.
Each system was simulated for 5 ns under constant temperature and pressure
using NAMD.43 The CHARMM36 force field,50 which has proven to be accurate for
Q10 systems,33,34 was used to calculate potential energies and forces. The TIP3P90
water model was used to model water in all simulations, along with the particle mesh
Ewald algorithm91 for full-system electrostatics with a grid spacing of 1.0 A˚. The
Verlet velocity algorithm45 was used to integrate the equations of motion with a time
step of 2 fs. All simulations were performed under constant pressure and temperature
(NPT) with a Langevin thermostat and piston utilized to maintain a temperature of
300 K and pressure of 1.013 25 bar respectively. A pair interaction cutoff of 12.0 A˚ was
used with a nonbonded switching distance of 10.0 A˚. All H-bonding ∆Hint analyses
were performed with the Tcl scripting interface in VMD.83
We defined ∆Hint as the sum of the Lennard-Jones (∆E
LJ
int) and Coulombic, or
electrostatic, potential energy (∆Eelecint ) terms, where the ∆ signifies the energy dif-
ference between an amide interaction at close distance and infinite separation. Due
to the negligible change in volume throughout the MD simulations, ∆Hint can be
accurately approximated as the change in internal energy of interaction (∆Eint). The
mathematical relationship is shown below.
∆Hint ≈ ∆Eint = ∆Eelecint + ∆ELJint (4.1)
When calculating ∆Hint, we define interacting groups as those with with heavy
atoms at distances of less than or equal to 5 A˚. Thus, our calculated ∆Hint is not
limited to strong H-bonding interactions, which generally occur for heavy atom dis-
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tances less than 3 A˚. For the Q10 antiparallel β-sheet conformation (Figure 4.1c), the
six innermost buried side chain and backbone amide groups were used to calculate
the ∆Hint because they best model the interior of the fibril core.
4.3 Evaluating the Comparative Strengths of Q10 Side Chain H-bonds
Table 4.1 contains the ∆Hint calculated for all the systems with both MD and
UVRR experiments. From experiment, ∆Hint values were calculated for solutions
of aqueous glutamine whose side chains are H-bonding with aqueous solvent. They
calculated a ∆Hint value of −4.3 kcal mol−1 for these glutamine water H-bonding
interactions. This served as a baseline of comparison for glutamine side chains H-
bonding to water in Q10 peptides.
We calculated ∆Hint of side chain↔water H-bonding for the PPII structural state
of monomeric Q10 (DQ10 or state B from Chapter 3) using both MD and UVRR. The
agreement for these calculated values is very good; UVRR experiments calculate a
value of −4.2 kcal mol−1 for PPII peptide↔water H-bonds while our MD experiments
yield a ∆Hint of −4.4 kcal mol−1. This indicates that Q10 side chains in the PPII
structural state are hydrated with the same energetic strength as the side chains of
single glutamine residues in solution, because the side chain↔water ∆Hint values are
similar between aqueous glutamine and PPII-rich Q10 monomers.
System Expt. ∆Hint MD ∆Hint H-bonding types
glutamine −4.3 − s.c.-w.
PPII monomer −4.2 −4.4 s.c.-w.
β-strand monomer −5.8,−4.3 −4.7,−4.4,−4.6 s.c.-s.c., s.c.-w., s.c.-b.b.
NDQ10 fibril −5.9 −6.2 s.c.-s.c.
DQ10 fibril −5.4 − s.c.-s.c.
Table 4.1: Side chain H-bonding ∆Hint values (kcal mol
−1) for different types of Q10
monomeric and fibril side chain interactions. MD simulations were not performed on
monomeric glutamine, thus no MD data is presented for that system; also we had no
way of obtaining an MD structure for fibrils prepared from PPII (DQ10) monomers.
We judged the extended antiparallel β-strand fibril model to be analagous to fibrils
prepared from NDQ10 peptides.
The H-bonding of aqueous Q10 peptides in β-strand conformations (NDQ10 or
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state A from Chapter 3) was also analyzed. UVRR was used to calculate ∆Hint
values for side chain↔backbone and side chain↔water H-bonds, and with MD we
calculated the strength of these, as well as side chain↔side chain H-bonds. With
UVRR, side chain↔backbone H-bonding in Q10 β-strands was estimated to have
an enthalpic strength of −5.8 kcal mol−1, significantly higher than the ∆Hint for side
chain↔water H-bonds, which was measured to be −4.3 kcal mol−1. MD-calculated
∆Hint values for β-strand Q10 H-bonding were −4.7, −4.4, and −4.6 kcal mol−1 for
side chain↔backbone, side chain↔water, and side chain↔side chain H-bonds, respec-
tively. UVRR and MD results agree well again for side chain↔water H-bonding, with
values of −4.3 and −4.4 kcal mol−1. Both methods yield larger ∆Hint values for side
chain↔backbone H-bonds than for side chain↔water, however UVRR estimates a
significantly higher ∆Hint of −5.8 kcal mol−1 compared to −4.7 kcal mol−1 calculated
from MD. However, the trend of side chain↔side chain H-bonds being stronger than
those of side chain↔water is conserved in both data. MD also was able to calculate
a ∆Hint value of −4.6 kcal mol−1 for side chain↔side chain H-bonds in β-strand Q10,
indicating that these interactions are comparable in energy to side chain↔backbone
H-bonds.
The enthalpic strength of Q10 fibril side chain H-bonding was also calculated
here. In Chapter 2, it was concluded that Q10 fibrils formed from the β-strand
(NDQ10) and PPII (DQ10) states were composed primarily of antiparallel extended
β-sheets. Our collaborators calculated ∆Hint values from UVRR spectra for Q10 fib-
rils prepared from both of these monomeric structural states to observe any energetic
differences. Computational ∆Hint values were obtained from MD simulations of the
octameric antiparallel extended β-sheet fibril (model a from Chapter 2) we previously
investigated. UVRR experiments yielded side chainside chain H-bond ∆Hint values of
−5.9 kcal mol−1 for fibrils prepared from β-strand monomers and −5.4 kcal mol−1 for
those prepared from PPII monomers. MD calculated side chain↔side chain ∆Hint
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values from the antiparallel β-sheet Q10 fibril were of strength −6.2 kcal mol−1.
These data indicate that the fibrils prepared from β-sheet and PPII monomers
are not entirely of an identical morphology; it seems that Q10 fibrils formed from
β-strand monomers feature side chain↔side chain H-bonding that is more similar
to the antiparallel β-sheet computational model than the fibrils formed from PPII
monomers. This may indicate that Q10 fibrils formed from PPII monomers are
composed of a more significant fraction of parallel β-sheets, which would form different
side chain-H-bonding patterns.
4.4 Conclusions and Direction
Our computational and experimental results show that ∆Hint values of side chain↔side
chain and side chain↔backbone interactions of Q10 monomeric and fibril structures
are enthalpically more favorable than side chain↔water interactions. This quantita-
tively confirms the hypotheses of various studies32,76,77,113 that argue that intrapeptide
H-bonding is the driving factor in the structural ensemble of monomer and aggregated
polyQ peptides. Interestingly, our results also indicate that side chain↔side chain H-
bonding is stronger in Q10 fibrils than backbonebackbone H-bonding. To our knowl-
edge, this work is the first study that experimentally and computationally quantifies
the energetic favorability of polyQ H-bonding interactions for polyQ monomers and
fibrils. In future work, we move away from the Q10 model peptide in the direction
of longer peptides with more physiological relevance. The same structural and H-
bonding analyses performed in Chapters 2,3, and 4 can be readily applied to these
longer peptides.
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Chapter 5. LENGTH DEPENDENT PROPERTIES IN THE STRUC-
TURE OF Q15 AND Q20 PEPTIDE MONOMERS AND FIBRILS
5.1 Overview of Length Dependent Properties in PolyQ Peptide Strucutre
The length of the polyQ tract in diseased proteins affects the severity of the
disease.10,11 Patients with longer polyQ tracts have an earlier disease age-of-onset,
and disease symptoms only occur if the proteins polyQ tract surpasses a critical
length.10,15,114 For example, clinical presentation of Huntington’s disease is only ob-
served in patients with a polyQ tract ≥36 residues long in the huntingtin protein.11
Additionally, in vitro studies of small polyQ peptides show that longer polyQ tracts
increase aggregation rates; this increase in aggregation rate may be related to the
disease age-of-onset.18,114
Because of the dependence of aggregation rate and disease age-of-onset on the
length of the polyQ tract, there is great interest in determining the structural differ-
ences between polyQ tracts of different lengths. Most experimental studies conclude
that solution-state polyQ peptides are intrinsically disordered regardless of the polyQ
tract length.18,96,110 However, some studies suggest the presence of small populations
of secondary structure, which may play a role in aggregation and cytotoxicity.18,110,114
In addition, computational studies agree that polyQ peptides are intrinsically disor-
dered regardless of repeat length.19,76,77,115
In Chapter 3, we used metadynamics simulations paired with UVRR spectroscopy
to investigate the solution-state structure of D2Q10K2 (Q10) peptides. We found that
Q10 can exist in a PPII-rich structure (referred to as DQ10) or a collapsed β-strand
conformation (NDQ10). There is a large activation barrier preventing interconversion
of these two structural states, and, interestingly, DQ10 was found to be more resistant
to fibrillization than NDQ10.
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5.2 Investigation of Q15 and Q20 monomeric structural properties with
MD and UVRR
Here, we utilized metadynamics MD simulations66 of monomeric D2Q15K2 (Q15)
and D2Q20K2 (Q20) peptides to characterize the structural ensembles of these pep-
tides. Classical MD simulations were performed on low energy structures taken from
these metadynamics simulations to calculate equilibrium statistics on structures oc-
cupying energy minima.
UVRR experiments were also done on monomeric and fibril samples of Q15 and
Q20 to calculate backbone Ψ dihedral angle distributions. Circular dichroism (CD)
spectroscopy experiments were carried out to probe the secondary structure of these
samples.
The Q15 peptide was solvated in 11 665 water molecules in a 72× 72× 72 A˚3 box,
and the Q20 peptide was solvated in 18 658 water molecules in a 84× 84× 84 A˚3 box.
These systems were prepared in VMD,83 and MD was simulated with NAMD.43 The
CHARMM3650 force field was used to calculate potential energies and forces, as it
had been used successfully in our previous studies.33–35 TIP3P90 was used as the water
model, and periodic boundary conditions were employed with a particle mesh Ewald91
grid spacing of 1.0 A˚. The Verlet velocity integration scheme was used to move the
atoms, and all simulations presented here were simulated under the NPT ensemble
of constant temperature 300 K and pressure 1.013 25 bar. A nonbonded interaction
cutoff of 12.0 A˚ was used with a pair-list distance of 14.0 A˚ and nonbonded switching
distance of 10.0 A˚.
We again used metadynamics to characterize the conformational free energy land-
scape for Q15 and Q20. Three RMSD coordinates were used as the collective variables
that made up the conformational phase space for the energy landscape, as explained
in Chapter 2. As previously, α-helix, β-hairpin, and PPII reference structures were
used for these RMSD coordinates, and the RMSD measurement was conducted in
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reference to the backbone atoms of the Q15 and Q20 peptides. The maximum al-
lowable RMSD value for the coordinates was 15.0 A˚ and 20.0 A˚ for the Q15 and Q20
simulations respectively, and these limits were maintained with harmonic restraints
of the form 1
2
k(x− x0)2 with a force constant of 1.0 kcal mol−1 A˚−1. Gaussian energy
hills of height 1.0 kcal mol−1 and width 3.0 A˚ were added to the potential energy of
the simulation every 500 steps to explore the conformational energy landscape.
Each monomeric structure was minimized for 10 000 steps using the conjugate
gradient minimization scheme43 and subsequently equilibrated at the correct temper-
ature and pressure for 500 ps. Metadynamics were then simulated on the two peptide
systems for a total of 400 ns each. This was considered to be sufficient sampling using
metadynamics guidelines developed by Laio et al.,70 see Equation 1.11.
Following these simulations, analysis of the metadynamics data was performed
using VMD83 along with custom Python scripts to locate low energy regions on the
energy landscape and correlate those regions to sections of the MD trajectory. The
structures occupying the local and global minima of the landscapes were then ex-
tracted using VMD.83 These structural states, two for Q15 and two for Q20, were
then simulated using classical MD for a further 10 ns to gather equilibrium statistics
for comparison to experiment. Potential energies and backbone Ψ dihedral angles
were then obtained from the classical MD simulations using Tcl scripting in VMD.83
The R statistical package was used to visualize the landscapes.94
5.3 Determination of Length Dependent Structural Properties for Q10,
Q15, and Q20
Our collaborators find that Q15 can exist in two distinct structural states similar
in structure to the PPII-rich (DQ10) and collapsed β-strand (NDQ10) states observed
in Chapter 3. These are referred to as NDQ15 and DQ15; Ψ angle distributions for
each of these states calculated from the UVRR spectra are shown in Figure 5.1a,b.
The Ψ distribution for NDQ15 shows a characteristic strong peak at 140◦ that
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Figure 5.1: UVRR-obtained Ψ angle distributions of monomeric (a) NDQ15, (b)
DQ15, and (c) DQ20. Computational Ψ angle distributions from metadynamics MD
simulations for (d) Q15 β-strand, (e) Q15 PPII state, (f) Q20 PPII state, and (g)
Q20 β-strand state. MD and UVRR distributions for monomeric Q10 can be found
in Chapter 3. Source: figure prepared with Python package Matplotlib and Adobe
Illustrator.
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indicates the β-strand structure we previously observed in NDQ10. DQ10 yields a
distribution (Figure 5.1c) that features a doublet peak with a maximum at 150◦,
corresponding to PPII structure, and shoulder peak located at 175◦, indicative of the
2.51 type structure that we previously found was caused by the ionized aspartate and
lysine terminal residues. Q20 was not able to be prepared in the collapsed β-strand
state due to its marginal solubility, and UVRR spectra were only obtainable for the
PPII state (referred to here as DQ20). The Ψ angle distribution calculated for this
state is similar to the distribution for DQ15, with strong peaks that imply PPII and
2.51 structures. Interestingly, both DQ15 and DQ20 possess minor peaks around 0
◦
that likely correspond to β-turn structural elements.
The results of the Q15 and Q20 conformational free energy landscapes from the
metadynamics simulations are depicted in Figures 5.2 and 5.3.
Low-energy structures are identified by blue and purple colors on the energy land-
scape, as described in the legend next to each landscape. As was previously observed
for Q10, the landscapes for Q15 and Q20 are frustrated, containing many shallow
minima rather than small clearly defined energy wells. In both landscapes we ob-
serve two deep energy basins that are labeled Energy Well 1 and 2 on the landscapes.
Representative structures populating these minima are displayed in Figure 5.2 with
arrows indicating the wells they are located in. These structures were simulated
with classical MD, and Ψ angle distributions were calculated. Notably, we find that
the structures that populate the wells on the Q15 and Q20 landscape are relatively
similar.
The Ψ angle distributions calculated from the MD simulations are shown in Fig-
ure 5.1d-g. Structures populating Energy Well 1 in both Q15 and Q20 have strong
peaks at 140◦, which is very close to the peak observed in the Ψ distribution for
NDQ15, consistent with β-strand type structure. Because of this, we designate En-
ergy Well 1 as the state corresponding to the collapsed β-strand conformation found
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Figure 5.2: Conformational energy landscape for monomeric Q15 from metady-
namics MD simulations. The lowest energy states are represented by the dark violet
isosurfaces with example structures from the salient structural states shown. Source:
figure prepared with R94 and Adobe Illustrator.
in the NDQ10 and NDQ15 peptides. For structures simulated from Energy Well 2,
we find that the Ψ angle distribution has a peak at ∼150◦, which is consistent with
a PPII-like conformation. There is also a minority population in the Ψ distribution
centered at ∼0◦, characteristic of β-turn-like structure. The β-turn elements allow
the PPII-rich structure to be collapsed for Q15 and Q20. The Ψ angle distributions
for the Q15 and Q20 structures in Energy Well 2 in Figure 5.1 match the distribu-
tions observed for DQ15 and DQ20. Thus, we conclude that Energy Well 2 contains
a predominately collapsed PPII-like structure interspersed with β-turn elements.
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Figure 5.3: Conformational energy landscape for monomeric Q20 from metady-
namics MD simulations. The lowest energy states are represented by the dark violet
isosurfaces with example structures from the salient structural states shown. Source:
figure prepared with R94 and Adobe Illustrator.
The Ψ angle distributions calculated from the UVRR spectra of DQ15 and DQ20
have peaks at ∼175◦ which are thought to be caused by 2.51-helix conformations.
These peaks are not observed in the PPII-like structures from the metadynamics
simulations. As discussed in Chapter 3, this discrepancy likely stems from an inad-
equacy in the CHARMM36 force field. Modern force fields are parameterized using
X-ray and NMR structures of proteins, and 2.51-helix structures are uncommon struc-
tures that occur only in peptides with adjacent charged residues. Hence, it is unlikely
that these structures would be favored by CHARMM36.
One obvious difference between the β-strand-like and PPII-like energy wells in
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the metadynamics simulations is the breadth of the energy well. The β-strand-like
energy well in the metadynamics simulations is conformationally broad, expanding a
wide range of RMSD values. As a result, the metadynamics β-strand-like structure
can vary with a low free energy cost. This suggests that the β-strand-like structure is
flexible and may have significant conformational fluctuations. In contrast, the PPII-
like energy well is narrow, indicating a more well-defined structure with less structural
fluctuations.
Overall, our metadynamics simulations agree with our UVRR data showing that
the structure of NDQ15 is predominately a β-strand-like conformation while the struc-
ture of DQ15 and DQ20 is predominantly a PPII-like conformation. This result is
similar to that previously reported for DQ10 and NDQ10. We show that the ex-
perimental Ψ angle distributions for DQ15 and DQ20 quantitatively agree with that
from the Q15 and Q20 PPII-like metadynamics structures. Similarly, the experi-
mental Ψ angle distribution for NDQ15 quantitatively matches that from of the Q15
β-strand-like metadynamics structure.
The final aspect of this study was a CD spectroscopy analysis of the observed
NDQ15, DQ15, and DQ20 structures. The CD spectra for these peptides is shown
in Figure 5.4 and clearly indicate that DQ15 and DQ20 possess PPII secondary
structure and NDQ15 has β-strand-like structure. However, compared to CD spectra
collected for Q10, both the DQ15 and DQ20 spectra show a more negative and slightly
redshifted peak at ∼220 nm and slightly more positive peak at ∼190 nm compared
to DQ10. To probe these differences, our collaborators subtracted the DQ10 spectra
from the spectra for DQ15 and DQ20. Interestingly, the difference spectrum contains
a negative peak at ∼220 nm and a stronger positive peak around 195 nm, which is
characteristic of β-strand conformations and similar to the CD spectra for NDQ15.
More so, the amount of β-strand character is greater in the spectra for DQ20 than
the spectra for DQ15.
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Figure 5.4: Solution-state CD spectra for DQ15, NDQ15, and DQ20 monomers.
NDQ20 spectra was not obtainable because the peptide was not soluble. Source:
figure prepared with Microsoft Excel.
This result indicates that residues in the PPII conformations (DQ15 and DQ20)
have decreased PPII character and increased β-strand character, and we observe
this trend increasing with polyQ repeat length. This conclusion was also drawn by
Chellgren et al.,98 who found increasing β-strand character with increasing polyQ
tract length.
The increased β-strand character in DQ15 and DQ20 peptides may suggest that
longer polyQ peptides have a stronger preference for the β-strand-like structure com-
pared to PPII structure. To investigate this, we examined the relative energies of the
β-strand and PPII energy wells and associated energy barriers from the conforma-
tional free energy landscapes for Q15 and Q20. We also included data from the Q10
monomeric energy landscape calculated in Chapter 3.
Table 5.1 shows the relative Gibbs free energy minima of the β-strand-like and
PPII-like energy wells from the metadynamics energy landscapes of Q10, Q15, and
Q20. For each peptide, the PPII-like conformation has a higher energy compared
to the β-strand conformation. We find that the PPII-like conformation increases in
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β-strand PPII-like
Peptide ∆G (kcal mol−1) ∆G (kcal mol−1)
Q10 0.0 0.0
Q15 0.0 2.0
Q20 0.0 2.0
Table 5.1: Relative free energy of lowest energy conformations for Q10, Q15, and
Q20. Here, 0.0 represents the lowest ∆G value.
energy with respect to the β-strand-like conformation as the polyQ repeat length
increases. This result indicates that the PPII-like conformation is less energetically
favorable compared to the β-strand conformation for longer polyQ peptides. This is
in agreement with work by Darnell et al.,109 who used CD spectroscopy to probe the
structure of polyQ peptides of increasing lengths. They observed PPII-like conforma-
tion decreasing and β-sheet content increasing with longer glutamine repeats. From
this result they conclude that polyQ peptides are in a “tug of war” between PPII and
β-strand structures, and as the repeat length increases this balance turns in favor of
β-strand structures.
β-strand to PPII PPII to β-strand
Peptide ∆G barrier (kcal mol−1) ∆G barrier (kcal mol−1)
Q10 5.8 5.3
Q15 5.2 3.1
Q20 4.6 2.3
Table 5.2: Transition energy barriers between conformations of interest for Q10,
Q15, and Q20. Here, 0.0 represents the lowest ∆G value.
Table 5.2 contains the various energy barriers between the PPII and β-strand
states observed in their respective conformational energy landscapes. These barriers
represent the lowest energy pathway between the energy minima. We find that the
PPII to β-strand activation barriers are lower in comparison to the β-strand to PPII
barriers for Q10, Q15, and Q20. Also, longer polyQ peptides have a lower activation
barrier for the PPII to β-strand conversion. This suggests that longer polyQ peptides
are increasingly capable of converting from PPII structures to β-strands, a conclusion
that agrees with the proposition that longer polyQ peptides adopt β-strand prefer-
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entially in comparison to PPII structures.
5.4 Conclusions and Direction
This work has shown that monomeric Q15 and Q20, like Q10, can form PPII-rich
structures and β-strand-like conformations. We find that the PPII structures formed
by longer polyQ peptides are more collapsed than the PPII conformations shown by
Q10. This indicates that the monomeric polyQ ensemble that determines the first
step of the aggregation process is indeed repeat length dependent. The real impact
of this work was the observation from both CD spectroscopy and metadynamics that
increasing polyQ repeat lengths preferentially adopt β-strand structures in compari-
son to PPII structures. This is supported by the energy landscapes, which show lower
energy barriers for the PPII to β-strand transition as the number of glutamine re-
peats increases. An important question in the field is why longer polyQ peptides form
cytotoxic aggregates when even short polyQ peptides (i.e. Q10) can aggregate into
fibrils in vitro. The work here suggests a framework for understanding why this is the
case, as β-strand-rich peptides more rapidly form fibrils, and β-strand-rich peptides
are favored in longer glutamine sequences.
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Chapter 6. CONCLUSION
6.1 Summary of Dissertation Work
In this dissertation, we set out to deepen our understanding of the aggregation
mechanism for polyQ peptides. The molecular mechanism of aggregation for polyQ-
rich peptides is key to understanding and potentially treating polyQ diseases. Par-
ticularly, development of drugs that can bind to polyQ peptides and inhibit the
aggregation process is dependent on knowledge of the different polyQ structures that
exist along the aggregation mechanism.72,79–81 This dissertation sought to provide
such knowledge by investigating the structure and thermodynamics of various polyQ
states along the aggregation mechanism (example shown in Figure 1.3).
In the first study33 (Chapter 2), we used MD simulations along with UVRR spec-
troscopy experiments to investigate the structural properties of D2Q10K2 (Q10) pep-
tide fibrils. We were able to determine, by comparing Ψ dihedral angle distributions
for three computational models of Q10 fibrils with distributions calculated from our
collaborator’s UVRR spectra, that Q10 fibrils primarily adopt an extended, antipar-
allel β-sheet fibril structure which corresponded to the computational Model a. The
fibril in Model a was observed to be stabilized by not only the backbone H-bonding
typical for β-sheets, but also organized side chain H-bonding enabled by a side chain
“zipper” conformation where the χ3 side chain dihedral angle enables close packing
of side chains. These results stand in contrast to studies of similar peptides which
suggest they adopt β-hairpin conformations in fibrils.36,37 This conclusion establishes
that extended antiparallel β-sheet structure is present in the aggregation mechanism
for short polyQ peptides. The successful pairing of theory and experiment used in
this study inspired us to use the same approach to study the monomeric structure of
Q10.
Monomeric structure of polyQ peptides is an area of greater contention than that
of polyQ fibrils. Using metadynamics MD simulations66 of aqueous Q10 peptides,
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we were able to characterize the entire conformational free energy landscape of this
peptide. We observed two deep conformational energy minima that corresponded to
PPII-rich and collapsed β-strand structural states for Q10. Our collaborators found
that they can poise Q10 to adopt two separate structural states, referred to as DQ10
and NDQ10. By analyzing and comparing distributions of backbone Ψ dihedral an-
gles calculated from both MD and UVRR, we determined that the experiment DQ10
peptide corresponded to the PPII-rich structural state from the MD and the NDQ10
peptide had the properties of the collapsed β-strand state. The conformational energy
landscape we calculated with metadynamics indicated that these states were sepa-
rated by a 3 to 6 kBT energy barrier. Experimentally, these peptide structural states
were unable to interconvert at 300 K, confirming the presence of this energy barrier.
H-bonding analysis indicated that the collapsed β-strand conformational state was
stabilized by an increased number of intrapeptide H-bonds, particular interactions be-
tween the side chain and backbone. Conversely, the PPII-rich state featured increased
peptide↔water H-bonds and less intrapeptide interactions. The results from this
study showed for the first time that monomeric polyQ peptides can populate distinct
structural states; most literature in the past had concluded that polyQ monomers
possess disordered structural ensembles.19,75,76,97 With these results, the initial steps
of the polyQ aggregation mechanism are better understood. It is apparent that a
β-hairpin aggregation scheme (seen on the right pathway in Figure 1.3) is not the
correct mechanism for short polyQ peptide aggregation. Instead, the presence of a
low energy β-strand monomeric structure gives creedence to the type of aggregation
mechanism shown on the left side of Figure 1.3. We set out next to better quantify
the effect that H-bonding has on Q10 structure.
Although H-bonding of the glutamine side chain is reported to be a driving force
of polyQ structure,32,76,77,115 no quantitative analyses of polyQ H-bonding strengths
had been published. Here (Chapter 4), we strove to do this by again pairing the-
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oretical and experimental methods. Our collaborators utilized the amide carbonyl
band’s linear frequency dependence on H-bonding environment to develop a method
to calculate a change in enthalpy of interaction (∆Hint) that occurs when a secondary
amide interacts with a H-bonding environment. Using MD simulations, we are able
to calculate an analogous value by computing the difference in energy between an in-
teraction and a lack of interaction. We calculated experimental and theoretical ∆Hint
values for various types of side chain H-bonds in Q10 monomers and fibrils. ∆Hint
values calculated from MD simulations agreed nicely with those calculated from the
UVRR spectra. This study showed that amideamide H-bonds formed by glutamine
side chains to other side chains or backbone are stronger than H-bonds from polyQ
side chains to water. An analysis of Q10 fibril side chain H-bonding demonstrated
that the side chain H-bonds present in antiparallel β-sheet Q10 fibrils are enthalpically
stronger than backbone H-bonds. These findings suggest that side chain H-bonding is
an enthalpic driving force in the formation of collapsed polyQ peptide structures and
an important stabilizing force in the formation of polyQ fibrils. Thus, polyQ struc-
tures that maximize peptide↔peptide H-bonding will be favored in the aggregation
mechanism, and this may provide insight in determining unknown oligomeric polyQ
structures. The last project we undertook was the application of some of the analyses
from the studies of Q10 to peptides of longer sequence (Q15, Q20) to determine any
repeat length dependent structural properties of polyQ peptides.
In Chapter 5 we used UVRR and metadynamics MD simulations to investigate the
structural ensemble of D2Q15K2 (Q15) and D2Q20K2 (Q20) monomers. Metadynamics
was used to calculate conformational free energy landscapes for these two peptides,
and structures from the energy minima were simulated further with classical MD.
UVRR and CD experiments were used to quantify backbone Ψ angle distributions
and secondary structure content respectively. We observed that the conformational
energy landscapes for Q15 and Q20 were relatively similar and both featured energy
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wells corresponding to β-strand and PPII-rich structures. However, for these longer
peptides the PPII-rich structures were collapsed, compared to the more extended
PPII structures observed for Q10. Experimentally, it was found that Q15 could form
DQ15 or NDQ15 peptides which correspond to the PPII and β-strand structures re-
spectively. Due to its low solubility in water, Q20 was not able to be prepared in the
NDQ20 state, so data for only DQ20 was collected. The NDQN type structures cor-
responded to β-strand structures observed in the conformational energy landscapes,
and the DQN type structures corresponded to the PPII. The CD spectra echoed these
results, but with an interesting observation: as the repeat length increased, more β-
strand structure was observed in the PPII samples. β-strand monomers are known to
form fibrils much more quickly than PPII monomers. Activation barriers and energy
differences observed in the theoretical conformational landscapes strengthened these
observations. As the glutamine repeat length increased, the PPII state relatively
free energy rose compared to the β-strand. Also, as repeats increased the activation
barrier for transition from PPII to β-strand decreased. These theoretical and ex-
perimental observations imply that increasing the length of polyQ repeats favors the
formation of β-strand monomeric structures, which is a major finding in terms of the
polyQ aggregation mechanism. This is an important finding, because it presents a
framework for understanding why long polyQ repeats tend to aggregate more quickly
in the cells of patients of polyQ diseases.
6.2 Future Directions and Unanswered Questions
Although we have uncovered interesting results in the four publications presented
here, there is much more that needs to be understood in the field to build a compre-
hensive understanding of the aggregation mechanism of polyQ peptides, and thus the
molecular pathology of polyQ diseases. Several questions that remain unresolved are
posited here.
1. What are the morphologies of polyQ fibrils formed by peptides of longer repeat
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lengths? Q10 has been shown to form fibrils that have a simple, relatively
homogeneous antiparallel β-sheet structure. However, for longer polyQ peptides
with a more flexible monomeric structural ensemble, this seems less likely. This
might be approached by using MD simulations compared with UVRR, as we did
for Q10 fibrils in Chapter 2, to determine the structural makeup of fibrils formed
by longer polyQ fibrils. An appropriate choice of glutamine repeat length would
be Q36, as this is the critical length for the appearance of Huntington’s disease.
10
2. What role do aggregates and fibrils play in the pathology of polyQ diseases?
Some studies have suggested that mature, insoluble fibrils actually play a ben-
eficial role in the pathology of these diseases by sequestering smaller, soluble
cytotoxic aggregates that disrupt function.21,95 However, this is not agreed upon
throughout the field. Better understanding the cytotoxic components of these
diseases would give biophysical researchers more specific species and mecha-
nisms to study. Marsh et al.95 have established that cytosolic purely polyQ
monomers are cytotoxic in Drosophila. An interdisciplinary approach could be
used, starting with experimental observation of a short sequence like Q10 in
the cell. Potential sites of polyQ interactions in the cell could then be modeled
with MD simulations to investigate the molecular mechanisms at play.
3. Although this work has established that increasing repeat lengths of polyQ se-
quences favor β-strand formation, this still leaves the question: what is unique
about the repeat length that actually causes these diseases to manifest? This
and other work has established that peptides well below physiological repeat
lengths form amyloid-like fibrils, so what is special about the disease relevant
repeat lengths? To learn this, a thorough investigation of repeat length depen-
dent structural properties in polyQ monomers and fibrils is necessary, as well
as an understanding of the relationship between repeat length and aggregation
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mechanism. One such approach to the investigation of repeat length dependent
structure is presented in Chapter 5 of this dissertation, however only three re-
peat lengths were used; this study would need to be expanded into the range
of repeats that cause disease (Q21−55). An approach to determining how the
aggregation mechanism may be affected by increasing repeat length would re-
quire that various oligomeric states along the energy landscape (see Figure 1.3)
be characterized. This could be accomplished by evaluating the free energy
of formation for hypothesized oligomeric structures with MD simulations using
enhanced sampling methods such as umbrella sampling65 or metadynamics.66
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